1. Schoffer O, Wimberger P, Gerken M, Bierbaum V, Bobeth C, Rößler M, u. a. Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer: Evidence Based on Health Care Data from the WiZen Study. Geburtshilfe Frauenheilkd. Februar 2024;84(2):153-63.
  2. Bierbaum V, Bobeth C, Roessler M, Gerken M, Kleihues-van Tol K, Reissfelder C, u. a. Treatment in certified cancer centers is related to better survival in patients with colon and rectal cancer: evidence from a large German cohort study. World J Surg Oncol. 6. Januar 2024;22(1):11.
  3. Scobioala S, Parfitt R, Matulat P, Byrne J, Langer T, Troschel FM, u. a. The impact of the temporal sequence of cranial radiotherapy and platin-based chemotherapy on hearing impairment in pediatric and adolescent CNS and head-and-neck cancer patients: A report from the PanCareLIFE consortium. Int J Cancer. 15. Januar 2024;154(2):320-31.
  4. Schöttker B, Holleczek B, Hybsier S, Köhrle J, Schomburg L, Brenner H. Strong associations of serum selenoprotein P with all-cause mortality and mortality due to cancer, cardiovascular, respiratory and gastrointestinal diseases in older German adults. Eur J Epidemiol. 10. Januar 2024;
  5. Scholz-Kreisel P, Becker C, Kaiser M, Mahmoudpour SH, Voigt M, Ressing M, u. a. Subsequent primary neoplasms after childhood cancer therapy - design and description of the German nested case-control study STATT-SCAR. Cancer Causes Control. Januar 2024;35(1):33-41.
  6. Scholz M, Horn K, Pott J, Wuttke M, Kühnapfel A, Nasr MK, u. a. X-chromosome and kidney function: evidence from a multi-trait genetic analysis of 908,697 individuals reveals sex-specific and sex-differential findings in genes regulated by androgen response elements. Nat Commun. 18. Januar 2024;15(1):586.
  7. Nanz L, Keim U, Katalinic A, Meyer T, Garbe C, Leiter U. Epidemiology of Keratinocyte Skin Cancer with a Focus on Cutaneous Squamous Cell Carcinoma. Cancers (Basel). 31. Januar 2024;16(3).
  8. Lupo PJ, Chambers TM, Mueller BA, Clavel J, Dockerty JD, Doody DR, u. a. Nonchromosomal birth defects and risk of childhood acute leukemia: An assessment in 15‚ÄČ000 leukemia cases and 46‚ÄČ000 controls from the Childhood Cancer and Leukemia International Consortium. Int J Cancer. 1. Februar 2024;154(3):434-47.
  9. Güven DC, Thong MS, Arndt V. Survivorship outcomes in patients treated with immune checkpoint inhibitors: a scoping review. J Cancer Surviv. 4. Januar 2024;
  10. Eisemann N, Schumann L, Baltus H, Labohm L, Kraywinkel K, Katalinic A. Longer Survival From Melanoma in Germany: A Registry-Based Time Series Study. Dtsch Arztebl Int. 26. Januar 2024;(Forthcoming):arztebl.m2023.0242.
  11. De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, u. a. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. Lancet Oncol. 30. Januar 2024;S1470-2045(23)00646-0.
  12. Carré J, Herzog B, Reil D, Schneider C, Pflüger M, Löbel M, u. a. [Impact of the COVID-19 pandemic on the diagnosis and treatment of patients with head and neck cancer in Brandenburg and Berlin]. HNO. Februar 2024;72(2):90-101.
  13. Ziegler J, Gruendner J, Rosenau L, Erpenbeck M, Prokosch HU, Deppenwiese N. Towards a Bavarian Oncology Real World Data Research Platform. Stud Health Technol Inform. 12. September 2023;307:78-85.
  14. Zeissig SR, Emrich K, Reinwald F, Kasper B, Kleihues-van Tol K, Justenhoven C, u. a. Sarcoma Research with Cancer Registry Data: Data and Peculiarities of Germany in the Light of Other Countries. Oncol Res Treat. 2023;46(9):370-81.
  15. Zahnreich S, Yusifli K, Poplawski A, Eckhard LS, Mirsch J, Hankeln T, u. a. Replication stress drives chromosomal instability in fibroblasts of childhood cancer survivors with second primary neoplasms. DNA Repair (Amst). Februar 2023;122:103435.
  16. Yang K, Doege D, Thong MSY, Koch-Gallenkamp L, Weisser L, Bertram H, u. a. Diabetes mellitus in long-term survivors with colorectal, breast, or prostate cancer: Prevalence and prognosis. A population-based study. Cancer. 23. November 2023;
  17. Wolf S, Augustin M, Hagenström K, Garbe C, Baltus H, Eisemann N, u. a. Evaluation of skin cancer screening in Germany - Spatiotemporal associations between skin cancer screening and skin cancer mortality based on ambulatory claims data. J Dtsch Dermatol Ges. Dezember 2023;21 Suppl 5:22-31.
  18. Wolf S, Augustin M, Hagenström K, Garbe C, Baltus H, Eisemann N, u. a. Evaluation der Hautkrebsfrüherkennung in Deutschland - Raumzeitliche Assoziationen zwischen Hautkrebsfrüherkennung und Hautkrebsmortalität auf Grundlage ambulanter Abrechnungsdaten. J Dtsch Dermatol Ges. Dezember 2023;21 Suppl 5:22-32.
  19. Wichert K, Hoppe R, Ickstadt K, Behrens T, Winter S, Herold R, u. a. Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer. Eur J Epidemiol. Oktober 2023;38(10):1053-68.
  20. Wellbrock M, Spix C, Ronckers CM, Grabow D, Filbert AL, Borkhardt A, u. a. Temporal patterns of childhood cancer survival 1991 to 2016: A nationwide register-study based on data from the German Childhood Cancer Registry. Int J Cancer. 15. August 2023;153(4):742-55.
  21. Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R, u. a. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nat Genet. Dezember 2023;55(12):2065-74.
  22. Waldmann A, Borchers P, Katalinic A. Temporal trends in age- and stage-specific incidence of colorectal adenocarcinomas in Germany. BMC Cancer. 1. Dezember 2023;23(1):1180.
  23. Vonneilich N, Becher H, Bohn B, Brandes B, Castell S, Deckert A, u. a. Associations of Migration, Socioeconomic Position and Social Relations With Depressive Symptoms - Analyses of the German National Cohort Baseline Data. Int J Public Health. 2023;68:1606097.
  24. Völkel V, Steinger B, Koller M, Klinkhammer-Schalke M, Lindberg-Scharf P. Colorectal cancer survivors' long-term recollections of their illness and therapy up to seven years after enrolment into a randomised controlled clinical trial. BMC Cancer. 13. Februar 2023;23(1):149.
  25. Völkel V, Gerken M, Kleihues-van Tol K, Schoffer O, Bierbaum V, Bobeth C, u. a. Treatment of Colorectal Cancer in Certified Centers: Results of a Large German Registry Study Focusing on Long-Term Survival. Cancers (Basel). 15. September 2023;15(18).
  26. Voigtländer S, Hakimhashemi A, Grundmann N, Radespiel-Tröger M, Inwald EC, Ortmann O, u. a. Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany. J Cancer Res Clin Oncol. August 2023;149(10):7493-503.
  27. van Leeuwen M, Kieffer JM, Young TE, Annunziata MA, Arndt V, Arraras JI, u. a. Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire. J Cancer Surviv. August 2023;17(4):1111-30.
  28. van den Oever SR, de Beijer IAE, Kremer LCM, Alfes M, Balaguer J, Bardi E, u. a. Barriers and facilitators to implementation of the interoperable Survivorship Passport (SurPass) v2.0 in 6 European countries: a PanCareSurPass online survey study. J Cancer Surviv. 20. Februar 2023;
  29. Thong MSY, Doege D, Weißer L, Koch-Gallenkamp L, Jansen L, Bertram H, u. a. Persisting Deficits in Health-Related Quality of Life of Colorectal Cancer Survivors 14-24 Years Post-Diagnosis: A Population-Based Study. Curr Oncol. 14. März 2023;30(3):3373-90.
  30. Thomas M, Su YR, Rosenthal EA, Sakoda LC, Schmit SL, Timofeeva MN, u. a. Combining Asian-European Genome-Wide Association Studies of Colorectal Cancer Improves Risk Prediction Across Race and Ethnicity. medRxiv‚ÄĮ: the preprint server for health sciences. United States; 2023. S. 2023.01.19.23284737.
  31. Thomas M, Su YR, Rosenthal EA, Sakoda LC, Schmit SL, Timofeeva MN, u. a. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations. Nat Commun. 2. Oktober 2023;14(1):6147.
  32. Teufel A, Rodriguez I, Winzler C, Kokh D, Ebert MP, Surovtsova I, u. a. Clinical Characterization of HCC/CCA Mixed Cancers in a Population-based Cohort. J Gastrointestin Liver Dis. 22. Juni 2023;32(2):190-6.
  33. Teufel A, Meindl-Beinker NM, Hösel P, Gerken M, Roig A, Ebert MP, u. a. Characteristics and outcome of patients with small bowel adenocarcinoma (SBA). J Cancer Res Clin Oncol. Juli 2023;149(8):4579-90.
  34. Tetzlaff F, Nowossadeck E, Jansen L, Michalski N, Barnes B, Kraywinkel K, u. a. Widening area-based socioeconomic inequalities in cancer mortality in Germany between 2003 and 2019. Sci Rep. 19. Oktober 2023;13(1):17833.
  35. Sunguc C, Hawkins MM, Winter DL, Dudley IM, Heymer EJ, Teepen JC, u. a. Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study. Br J Cancer. Januar 2023;128(1):80-90.
  36. Struck JP, Ozimek T, Schnoor M, Offermann A, Guenther M, Roesch MC, u. a. The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder Tumours. Urol Int. 2023;107(8):792-800.
  37. Strebel S, Baust K, Grabow D, Byrne J, Langer T, Am Zehnhoff-Dinnesen A, u. a. Auditory complications among childhood cancer survivors and health-related quality of life: a PanCareLIFE study. J Cancer Surviv. 22. September 2023;
  38. Stocker H, Trares K, Beyer L, Perna L, Rujescu D, Holleczek B, u. a. Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years. Alzheimers Res Ther. 29. Juli 2023;15(1):129.
  39. Stocker H, Beyer L, Trares K, Perna L, Rujescu D, Holleczek B, u. a. Association of Kidney Function With Development of Alzheimer Disease and Other Dementias and Dementia-Related Blood Biomarkers. JAMA Netw Open. 3. Januar 2023;6(1):e2252387.
  40. Stocker H, Beyer L, Perna L, Rujescu D, Holleczek B, Beyreuther K, u. a. Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical Alzheimer's disease risk: Results from a prospective cohort followed over 17 years. Alzheimers Dement. Januar 2023;19(1):25-35.
  41. Stang A, Trocchi P, Kajüter H, Trabert B, Oosterhuis JW, McGlynn KA. Age-incidence patterns of seminoma and nonseminoma among males and females in Germany and the United States, 2008-2016. Andrology. Januar 2023;11(1):65-72.
  42. Stang A. A historical note about the sufficient cause model with special consideration of the work of Max Verworn 1912. Ann Epidemiol. September 2023;85:1-2.
  43. Spoerl S, Gerken M, Fischer R, Spoerl S, Kirschneck C, Wolf S, u. a. Statin Use Ameliorates Survival in Oral Squamous Cell Carcinoma-Data from a Population-Based Cohort Study Applying Propensity Score Matching. Biomedicines. 27. Januar 2023;11(2).
  44. Spoerl S, Erber R, Gerken M, Taxis J, Ludwig N, Nieberle F, u. a. A20 as a Potential New Tool in Predicting Recurrence and Patient's Survival in Oral Squamous Cell Carcinoma. Cancers (Basel). 21. Januar 2023;15(3).
  45. Spix C, Erdmann F, Grabow D, Ronckers C. Childhood and adolescent cancer in Germany - an overview. J Health Monit. Juni 2023;8(2):79-94.
  46. Schwedhelm C, Nimptsch K, Ahrens W, Hasselhorn HM, Jöckel KH, Katzke V, u. a. Chronic disease outcome metadata from German observational studies - public availability and FAIR principles. Sci Data. 5. Dezember 2023;10(1):868.
  47. Schütte W, Gütz S, Nehls W, Blum TG, Brückl W, Buttmann-Schweiger N, u. a. [Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer - Interdisciplinary Guideline of the German Respiratory Society and the German Cancer Society - Abridged Version]. Pneumologie. Oktober 2023;77(10):671-813.
  48. Schumann L, Eisemann N, Augustin J, Kieschke J, Meyer M, Kajüter H, u. a. Zusammenhang zwischen der Inzidenz früher Stadien und der Mortalität beim malignen Melanom - eine bevölkerungsbasierte ökologische Studie. J Dtsch Dermatol Ges. Dezember 2023;21 Suppl 5:33-41.
  49. Schumann L, Eisemann N, Augustin J, Kieschke J, Meyer M, Kajüter H, u. a. Association of early-stage incidence and mortality in malignant melanoma - a population-based ecological study. J Dtsch Dermatol Ges. Dezember 2023;21 Suppl 5:33-40.
  50. Schuldt K, Trocchi P, Stang A. Skin Cancer Screening and Medical Treatment Intensity in Patients with Malignant Melanoma and Non-Melanocytic Skin Cancer. Dtsch Arztebl Int. 20. Januar 2023;120(3):33-9.
  51. Schraw JM, Petridou ET, Bonaventure A, Dockerty JD, Karalexi M, Ntzani E, u. a. Breastfeeding and risk of childhood brain tumors: a report from the Childhood Cancer and Leukemia International Consortium. Cancer Causes Control. November 2023;34(11):1005-15.
  52. Schneider J, Hernandez D, Schlander M, Arndt V. Out-of-pocket payments and loss of income among long-term breast cancer survivors in Germany: a multi-regional population-based study. J Cancer Surviv. Dezember 2023;17(6):1639-59.
  53. Schmitt J, Klinkhammer-Schalke M, Bierbaum V, Gerken M, Bobeth C, Rößler M, u. a. Initial Cancer Treatment in Certified Versus Non-Certified Hospitals. Dtsch Arztebl Int. 29. September 2023;120(39):647-54.
  54. Schmitt J, Bierbaum T, Geraedts M, Gothe H, Härter M, Hoffmann F, u. a. [Not Available]. Gesundheitswesen. April 2023;85(4):215-22.
  55. Schliemann A, Teroerde A, Beurer B, Hammersen F, Fischer D, Katalinic A, u. a. Reduced Psychosocial Well-Being among the Children of Women with Early-Onset Breast Cancer. Curr Oncol. 21. November 2023;30(12):10057-74.
  56. Scharl S, Sprötge T, Gerken M, Scharl A, Ortmann O, Kölbl O, u. a. Guideline concordant therapy improves survival in high-grade endometrial cancer patients. J Cancer Res Clin Oncol. Juli 2023;149(8):4761-9.
  57. Russo A, Blettner M, Merzenich H, Wollschlaeger D, Erdmann F, Gianicolo E. Incidence of childhood leukemia before and after shut down of nuclear power plants in Germany in 2011: A population-based register study during 2004 to 2019. Int J Cancer. 1. März 2023;152(5):913-20.
  58. Rudolph C, Engholm G, Pritzkuleit R, Storm HH, Katalinic A. Colorectal Cancer Survival in German-Danish Border Regions-A Registry-Based Cohort Study. Cancers (Basel). 8. September 2023;15(18).
  59. Reulen RC, Winter DL, Diallo I, Veres C, Llanas D, Allodji RS, u. a. Risk Factors for Primary Bone Cancer After Childhood Cancer: A PanCare Childhood and Adolescent Cancer Survivor Care and Follow-Up Studies Nested Case-Control Study. J Clin Oncol. 20. Juli 2023;41(21):3735-46.
  60. Ressing M, Becker C, Müller C, Mahmoudpour SH, Calaminus G, Langer T, u. a. Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factors. Cancer Rep (Hoboken). Mai 2023;6(5):e1811.
  61. Reinwald F, Justenhoven C. Impact of the COVID-19 pandemic on number and stages of tumors - data of a German cancer registry. Acta Oncol. März 2023;62(3):315-7.
  62. Petruch N, Servin Rojas M, Lillemoe KD, Castillo CFD, Braun R, Honselmann KC, u. a. The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national registries. Surgery. 12. Dezember 2023;S0039-6060(23)00844-9.
  63. Perna L, Stocker H, Burow L, Beyer L, Trares K, Kurz C, u. a. Subjective cognitive complaints and blood biomarkers of neurodegenerative diseases: a longitudinal cohort study. Alzheimers Res Ther. 11. November 2023;15(1):198.
  64. Perna L, Mons U, Stocker H, Beyer L, Beyreuther K, Trares K, u. a. High cholesterol levels change the association of biomarkers of neurodegenerative diseases with dementia risk: Findings from a population-based cohort. Alzheimers Dement. Juli 2023;19(7):2913-22.
  65. Neis F, Holleczek B, Henes M, Juhasz-Böss I, Wallwiener D, Neis KJ. Proposal for a descriptive and differentiated presentation of the longitudinal impact of the new organized cancer screening guideline and HPV vaccination in Germany. Arch Gynecol Obstet. April 2023;307(4):1125-36.
  66. Nachtsheim L, Mayer M, Meyer MF, Oesterling F, Kajueter H, Arolt C, u. a. Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany. J Cancer Res Clin Oncol. Juli 2023;149(7):3811-21.
  67. Mueller SH, Lai AG, Valkovskaya M, Michailidou K, Bolla MK, Wang Q, u. a. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome Med. 26. Januar 2023;15(1):7.
  68. Morawitz J, Sigl B, Rubbert C, Bruckmann NM, Dietzel F, Häberle LJ, u. a. Clinical Decision Support for Axillary Lymph Node Staging in Newly Diagnosed Breast Cancer Patients Based on (18)F-FDG PET/MRI and Machine Learning. J Nucl Med. Februar 2023;64(2):304-11.
  69. Morawitz J, Bruckmann NM, Jannusch K, Dietzel F, Milosevic A, Bittner AK, u. a. Conventional Imaging, MRI and (18)F-FDG PET/MRI for N and M Staging in Patients with Newly Diagnosed Breast Cancer. Cancers (Basel). 17. Juli 2023;15(14).
  70. Möller L, Wellmann I, Stang A, Kajüter H. The Epidemiology of Colorectal Cancer in Younger and Older Patients. Dtsch Arztebl Int. 21. April 2023;120(16):277-83.
  71. Möhl A, Behrens S, Flaßkamp F, Obi N, Kreienbrinck A, Holleczek B, u. a. The impact of cardiovascular disease on all-cause and cancer mortality: results from a 16-year follow-up of a German breast cancer case-control study. Breast Cancer Res. 27. Juli 2023;25(1):89.
  72. Middha P, Wang X, Behrens S, Bolla MK, Wang Q, Dennis J, u. a. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry. Breast Cancer Res. 9. August 2023;25(1):93.
  73. Meyer S, Buser L, Haferkamp S, Berneburg M, Maisch T, Klinkhammer-Schalke M, u. a. Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I-IIA cutaneous melanoma. Eur J Cancer. März 2023;182:77-86.
  74. Matz M, Valkov M, ҆ekerija M, Luttman S, Caldarella A, Coleman MP, u. a. Worldwide trends in esophageal cancer survival, by sub-site, morphology, and sex: an analysis of 696,974 adults diagnosed in 60 countries during 2000-2014 (CONCORD-3). Cancer Commun (Lond). September 2023;43(9):963-80.
  75. Machens A, Lorenz K, Huessler EM, Stang A, Weber F, Dralle H. Temporal trends in referrals of RET gene carriers for neck surgery to a tertiary surgical center in the era of international management guidelines. Endocrine. April 2023;80(1):100-10.
  76. Lodde GC, Hassel J, Wulfken LM, Meier F, Mohr P, Kähler K, u. a. Adjuvant treatment and outcome of stage III melanoma patients: Results of a multicenter real-world German Dermatologic Cooperative Oncology Group (DeCOG) study. Eur J Cancer. September 2023;191:112957.
  77. Liu Z, Thong MSY, Doege D, Koch-Gallenkamp L, Weisser L, Bertram H, u. a. Benefit finding, posttraumatic growth and health-related quality of life in long-term cancer survivors: a prospective population-based study. Acta Oncol. September 2023;62(9):1124-31.
  78. Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T, u. a. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. J Med Genet. 27. November 2023;60(12):1186-97.
  79. Leiter U, Heppt MV, Steeb T, Alter M, Amaral T, Bauer A, u. a. [S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 2: Epidemiologie und ätiologie, Diagnostik, Therapie des invasiven Plattenepithelkarzinoms der Haut, Nachsorge und Prävention: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention]. J Dtsch Dermatol Ges. November 2023;21(11):1422-34.
  80. Leiter U, Heppt MV, Steeb T, Alter M, Amaral T, Bauer A, u. a. S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention. J Dtsch Dermatol Ges. November 2023;21(11):1422-33.
  81. Lang LM, Behr C, Ludwig M, Walker J, Christian Lange H, Basedow F, u. a. Routine practice data of three cancer entities: Comparison among cancer registry and health insurance data. Z Evid Fortbild Qual Gesundhwes. April 2023;177:65-72.
  82. Kraywinkel K, Flegar L, Huber J, Groeben C. [Cancer registries in Germany: what does the future hold for urology?]. Aktuelle Urol. Juni 2023;54(3):208-12.
  83. Konermann FM, Gessler N, Wohlmuth P, Behr J, Feldhege J, Gloeckner C, u. a. High In-Hospital Mortality in SARS-CoV-2-Infected Patients with Active Cancer Disease during Omicron Phase of the Pandemic: Insights from the CORONA Germany Study. Oncol Res Treat. 2023;46(5):201-10.
  84. Klinkhammer-Schalke M, Wesselmann S, Bruns J, Nettekoven G, Tillack A, Follmann M, u. a. [Further Development and Interoperability in Oncological Care Structures, Quality Control and Research]. Gesundheitswesen. Juli 2023;85(7):649-56.
  85. Keim U, Katalinic A, Holleczek B, Wakkee M, Garbe C, Leiter U. Incidence, mortality and trends of cutaneous squamous cell carcinoma in Germany, the Netherlands, and Scotland. Eur J Cancer. April 2023;183:60-8.
  86. Katalinic A, Halber M, Meyer M, Pflüger M, Eberle A, Nennecke A, u. a. Population-Based Clinical Cancer Registration in Germany. Cancers (Basel). 2. August 2023;15(15).
  87. Jansen L, Schwettmann L, Behr C, Eberle A, Holleczek B, Justenhoven C, u. a. Trends in cancer incidence by socioeconomic deprivation in Germany in 2007 to 2018: An ecological registry-based study. Int J Cancer. 15. November 2023;153(10):1784-96.
  88. Jakob D, Schmoor C, Reuten R, Frevert ML, Dannehl D, Jansen L, u. a. Characteristics, Treatment Patterns and Survival of International Federation of Gynecology and Obstetrics Stage IV Epithelial Ovarian Cancer-A Population-Based Study. Cancers (Basel). 30. November 2023;15(23).
  89. Hübner J, Baltus H, Eisemann N, Rohr M, Schumann L, Augustin J, u. a. Evaluation of early skin cancer detection in Germany with cancer registry data - challenges, solutions and current trends. J Dtsch Dermatol Ges. Dezember 2023;21 Suppl 5:13-20.
  90. Hübner J, Baltus H, Eisemann N, Rohr M, Schumann L, Augustin J, u. a. Evaluation der Hautkrebsfrüherkennung in Deutschland mit Krebsregisterdaten - Herausforderungen, Lösungen und aktuelle Trends. J Dtsch Dermatol Ges. Dezember 2023;21 Suppl 5:13-21.
  91. Hintschich CA, Gerken M, Spoerl S, Bohr C, Künzel J. Primary Diagnoses of Squamous Cell Carcinoma of the Head and Neck During the COVID-19 Pandemic. Dtsch Arztebl Int. 20. Oktober 2023;120(42):719-20.
  92. Heywang-Köbrunner SH, Hacker A, Jänsch A, Hertlein M, Mieskes C, Elsner S, u. a. Use of novel artificial intelligence computer-assisted detection (AI-CAD) for screening mammography: an analysis of 17,884 consecutive two-view full-field digital mammography screening exams. Acta Radiol. Oktober 2023;64(10):2697-703.
  93. Hess T, Maj C, Gehlen J, Borisov O, Haas SL, Gockel I, u. a. Dissecting the genetic heterogeneity of gastric cancer. EBioMedicine. Juni 2023;92:104616.
  94. Hess T, Maj C, Gehlen J, Borisov O, Haas SL, Gockel I, u. a. Corrigendum to "Dissecting the genetic heterogeneity of gastric cancer". EBioMedicine. August 2023;94:104709.
  95. Herout R, Baunacke M, Flegar L, Borkowetz A, Reicherz A, Koch R, u. a. Upper tract urothelial carcinoma in Germany: epidemiological data and surgical treatment trends in a total population analysis from 2006 to 2019. World J Urol. Januar 2023;41(1):127-33.
  96. Heppt MV, Leiter U, Steeb T, Alter M, Amaral T, Bauer A, u. a. [S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care]. J Dtsch Dermatol Ges. Oktober 2023;21(10):1249-62.
  97. Heppt MV, Leiter U, Steeb T, Alter M, Amaral T, Bauer A, u. a. S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care. J Dtsch Dermatol Ges. Oktober 2023;21(10):1249-62.
  98. Heidenreich A, Fuchshofen R, Elsner S, Gieseler F, Katalinic A, Hübner J. Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany. J Cancer Res Clin Oncol. Dezember 2023;149(19):17297-306.
  99. Heidenreich A, Elsner S, Wörler F, Hübner J, Schües C, Rehmann-Sutter C, u. a. Physicians' perspectives on family caregivers' roles in elderly cancer patients' therapies: a qualitative, interview-based study. Support Care Cancer. 9. Juni 2023;31(7):387.
  100. Hatzipanagiotou ME, Pigerl M, Gerken M, Räpple S, Zeltner V, Hetterich M, u. a. Does timing of neoadjuvant chemotherapy influence the prognosis in patients with early triple negative breast cancer? J Cancer Res Clin Oncol. Oktober 2023;149(13):11941-50.
  101. Hammersen F, Fischer D, Pursche T, Strobel AM, Katalinic A, Labohm L, u. a. Young Adult German Breast Cancer Patients Participating in a Three-Week Inpatient Mother-Child Rehab Program Have High Needs for Supportive Care. Cancers (Basel). 15. März 2023;15(6).
  102. Grundmann N, Voigtländer S, Hakimhashemi A, Pape UF, Meyer M, Müller-Nordhorn J. Site-specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, Germany. Cancer Med. Oktober 2023;12(19):19949-58.
  103. Grandt CL, Brackmann LK, Poplawski A, Schwarz H, Marini F, Hankeln T, u. a. Identification of lncRNAs involved in response to ionizing radiation in fibroblasts of long-term survivors of childhood cancer and cancer-free controls. Front Oncol. 2023;13:1158176.
  104. Göbel S, Wingerter A, Prochaska JH, Schulz A, Neu MA, Henninger N, u. a. Development and Phenotype of Heart Failure in Long-Term Survivors of Childhood Cancer: The CVSS Study. J Am Heart Assoc. 3. Oktober 2023;12(19):e030020.
  105. Giusti F, Martos C, Trama A, Bettio M, Sanvisens A, Audisio R, u. a. Cancer treatment data available in European cancer registries: Where are we and where are we going? Front Oncol. 2023;13:1109978.
  106. Girschik C, Muchalla P, Kowall B, Zwanziger D, Erbel R, Ittermann T, u. a. [Regional Differences in Thyroid Function Parameters: A Comparison of European Cohort Studies]. Gesundheitswesen. März 2023;85(3):175-80.
  107. Girardi F, Matz M, Stiller C, You H, Marcos Gragera R, Valkov MY, u. a. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3). Neuro Oncol. 14. März 2023;25(3):580-92.
  108. Girardi F, Di Carlo V, Stiller C, Gatta G, Woods RR, Visser O, u. a. Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3). Neuro Oncol. 14. März 2023;25(3):593-606.
  109. Giaccherini M, Gori L, Gentiluomo M, Farinella R, Cervena K, Skieceviciene J, u. a. A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma. Carcinogenesis. 2. Dezember 2023;44(8-9):642-9.
  110. Garbe C, Augustin M, Augustin J, Baltus H, Eisemann N, Hübner J, u. a. Evaluation of skin cancer screening in Germany - participation, tumor detection and interval tumors based on SHI data. J Dtsch Dermatol Ges. Dezember 2023;21 Suppl 5:3-11.
  111. Garbe C, Augustin M, Augustin J, Baltus H, Eisemann N, Hübner J, u. a. Evaluation der Hautkrebsfrüherkennung in Deutschland - Teilnahme, Tumordetektion und Intervalltumoren auf Grundlage von GKV-Daten. J Dtsch Dermatol Ges. Dezember 2023;21 Suppl 5:3-12.
  112. Gali K, Orban E, Ozga AK, Möhl A, Behrens S, Holleczek B, u. a. Does breast cancer modify the long-term relationship between lifestyle behaviors and mortality? A prospective analysis of breast cancer survivors and population-based controls. Cancer. 11. November 2023;
  113. Galetzka W, Kowall B, Jusi C, Huessler EM, Stang A. Distance-Metric Learning for Personalized Survival Analysis. Entropy (Basel). 30. September 2023;25(10).
  114. Fischl A, Gerken M, Roos P, Haedenkamp T, Hillberg A, Klinkhammer-Schalke M, u. a. Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study. Neurooncol Pract. Oktober 2023;10(5):446-53.
  115. Fernandez-Rozadilla C, Timofeeva M, Chen Z, Law P, Thomas M, Schmit S, u. a. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nat Genet. Januar 2023;55(1):89-99.
  116. Fernandez-Rozadilla C, Timofeeva M, Chen Z, Law P, Thomas M, Schmit S, u. a. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nat Genet. März 2023;55(3):519-20.
  117. Fern√°ndez-Pacheco M, Gerken M, Ortmann O, Ignatov A, Klinkhammer-Schalke M, Hatzipanagiotou ME, u. a. Impact of cavity shaving on residual tumor rates in patients with primary invasive carcinoma and carcinoma in situ in breast conserving surgery. Arch Gynecol Obstet. Mai 2023;307(5):1573-83.
  118. Ernst M, Hinz A, Brähler E, Merzenich H, Faber J, Wild PS, u. a. Quality of life after pediatric cancer: comparison of long-term childhood cancer survivors' quality of life with a representative general population sample and associations with physical health and risk indicators. Health Qual Life Outcomes. 4. Juli 2023;21(1):65.
  119. Eisfeld C, Kajüter H, Möller L, Wellmann I, Shumilov E, Stang A. Time trends in survival and causes of death in multiple myeloma: a population-based study from Germany. BMC Cancer. 6. April 2023;23(1):317.
  120. Dudley IM, Sunguc C, Heymer EJ, Winter DL, Teepen JC, Belle FN, u. a. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study. Cancer. 1. Februar 2023;129(3):426-40.
  121. Dubrall D, Sachs B, Kraywinkel K, Schulz M, Schmid M, Fischer-Barth W, u. a. Analyses of Basal and Squamous Cell Carcinoma Reported as an Adverse Drug Reaction and Comparison with Cases from the Cancer Registry from Germany. Drugs R D. März 2023;23(1):21-33.
  122. Dimou N, Kim AE, Flanagan O, Murphy N, Diez-Obrero V, Shcherbina A, u. a. Probing the diabetes and colorectal cancer relationship using gene - environment interaction analyses. Br J Cancer. August 2023;129(3):511-20.
  123. Dieckmann KP, Isbarn H, Trocchi P, Kießling M, Wülfing C, Stang A. No evidence for seasonal variations of the incidence of testicular germ cell tumours in Germany. PLoS One. 2023;18(5):e0286309.
  124. Demuru E, Rossi S, Ventura L, Dal Maso L, Guzzinati S, Katalinic A, u. a. Estimating complete cancer prevalence in Europe: validity of alternative vs standard completeness indexes. Front Oncol. 2023;13:1114701.
  125. De Santis KK, Helmer S, Barnes B, Kraywinkel K, Imhoff M, Müller-Eberstein R, u. a. Impact of the COVID-19 pandemic on oncological care in Germany: rapid review. J Cancer Res Clin Oncol. November 2023;149(15):14329-40.
  126. de Beijer IAE, Hardijzer EC, Haupt R, Grabow D, Balaguer J, Bardi E, u. a. Barriers and facilitators to the implementation of a new European eHealth solution (SurPass v2.0): the PanCareSurPass Open Space study. J Cancer Surviv. 28. November 2023;
  127. de Baat EC, Feijen EAM, Reulen RC, Allodji RS, Bagnasco F, Bardi E, u. a. Risk Factors for Heart Failure Among Pan-European Childhood Cancer Survivors: A PanCareSurFup and ProCardio Cohort and Nested Case-Control Study. J Clin Oncol. 1. Januar 2023;41(1):96-106.
  128. Dahm S, Barnes B, Kraywinkel K. Detection of missed deaths in cancer registry data to reduce bias in long-term survival estimation. Front Oncol. 2023;13:1088657.
  129. Crispin-Rios Y, Faura-Gonzales M, Torres-Roman JS, Quispe-Vicu√Īa C, Franco-Jimenez US, Valcarcel B, u. a. Testicular cancer mortality in Latin America and the Caribbean: trend analysis from 1997 to 2019. BMC Cancer. 27. Oktober 2023;23(1):1038.
  130. Carus J, Trübe L, Szczepanski P, Nürnberg S, Hees H, Bartels S, u. a. Mapping the Oncological Basis Dataset to the Standardized Vocabularies of a Common Data Model: A Feasibility Study. Cancers (Basel). 11. August 2023;15(16).
  131. Carreras-Torres R, Kim AE, Lin Y, D√≠ez-Obrero V, Bien SA, Qu C, u. a. Genome-wide Interaction Study with Smoking for Colorectal Cancer Risk Identifies Novel Genetic Loci Related to Tumor Suppression, Inflammation, and Immune Response. Cancer Epidemiol Biomarkers Prev. 6. März 2023;32(3):315-28.
  132. Campa D, Gentiluomo M, Stein A, Aoki MN, Oliverius M, Vodińćkov√° L, u. a. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Crit Rev Oncol Hematol. Juni 2023;186:104020.
  133. Braulke F, Kober K, Rieken S, Brand T, Hartz T, Seipke S, u. a. Adherence to interdisciplinary tumor board recommendations as an expression of quality-assured patient care: results of a bicentric German analysis. J Cancer Res Clin Oncol. November 2023;149(16):14775-84.
  134. Brackmann LK, Foraita R, Schwarz H, Poplawski A, Hankeln T, Galetzka D, u. a. Self-administered questionnaire assessing childhood cancer treatments and associated risks for adverse health outcomes - The KiKme study. Front Oncol. 2023;13:1150629.
  135. Bobeth C, Tol KK van, Rößler M, Bierbaum V, Gerken M, Günster C, u. a. [Methodology and Attribution Success of a Data Linkage of Clinical Registry Data with Health Insurance Data]. Gesundheitswesen. März 2023;85(S 02):S154-61.
  136. Bhardwaj M, Schöttker B, Holleczek B, Brenner H. Enhanced selection of people for lung cancer screening using AHRR (cg05575921) or F2RL3 (cg03636183) methylation as biological markers of smoking exposure. Cancer Commun (Lond). August 2023;43(8):956-9.
  137. Arndt V, Doege D, Fröhling S, Albers P, Algül H, Bargou R, u. a. Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic. J Cancer Res Clin Oncol. Februar 2023;149(2):913-9.
  138. Aleshchenko E, Apfelbacher C, Baust K, Calaminus G, Droege P, Glogner J, u. a. VersKiK: Study protocol of an observational registry-based study on the current state of follow-up care and adherence to follow-up guidelines after cancer in childhood or adolescence. Cancer Epidemiol. Dezember 2023;87:102469.
  139. Aglago EK, Kim A, Lin Y, Qu C, Evangelou M, Ren Y, u. a. A Genetic Locus within the FMN1/GREM1 Gene Region Interacts with Body Mass Index in Colorectal Cancer Risk. Cancer Res. 1. August 2023;83(15):2572-83.
  140. Acs M, Gerken M, Schmitt V, Piso P, Königsrainer A, Baransi S, u. a. Role of HIPEC after Complete Cytoreductive Surgery (CRS) in Peritoneal Recurrence of Platinum-Sensitive Recurrent Ovarian Cancer (OC): The Aim for Standardization at Two Reference Centers for CRS. Cancers (Basel). 7. Januar 2023;15(2).
  141. Abdalla TSA, Pieper L, Kist M, Thomaschewski M, Klinkhammer-Schalke M, Zeissig SR, u. a. Gastrointestinal stromal tumors of the upper GI tract: population-based analysis of epidemiology, treatment and outcome based on data from the German Clinical Cancer Registry Group. J Cancer Res Clin Oncol. August 2023;149(10):7461-9.
  142. Abdalla TSA, Klinkhammer-Schalke M, Zeissig SR, Tol KK van, Honselmann KC, Braun R, u. a. Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers. J Cancer Res Clin Oncol. September 2023;149(11):8535-43.
  143. Zolk O, von dem Knesebeck A, Graf N, Simon T, Hero B, Abdul-Khaliq H, u. a. Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort Study. JMIR Res Protoc. 17. Februar 2022;11(2):e27898.
  144. Zhu A, Kuznia S, Niedermaier T, Holleczek B, Schöttker B, Brenner H. Vitamin D-binding protein, total, "nonbioavailable," bioavailable, and free 25-hydroxyvitamin D, and mortality in a large population-based cohort of older adults. J Intern Med. September 2022;292(3):463-76.
  145. Zhu A, Kuznia S, Niedermaier T, Holleczek B, Schöttker B, Brenner H. Consistent Inverse Associations of Total, "Bioavailable", Free, and "Non-Bioavailable" Vitamin D with Incidence of Diabetes among Older Adults with Lower Baseline HbA(1c) (‚ȧ6%) Levels. Nutrients. 11. August 2022;14(16).
  146. Yu H, Raut JR, Bhardwaj M, Zhang Y, Sandner E, Schöttker B, u. a. A serum microRNA signature for enhanced selection of people for lung cancer screening. Cancer Commun (Lond). November 2022;42(11):1222-5.
  147. Yang K, Liu Z, Thong MSY, Doege D, Arndt V. Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis. Cancers (Basel). 2. April 2022;14(7).
  148. Wellbrock M, Zeeb H, Spix C, Grabow D, Borkhardt A, Erdmann F. Survival in Children Below the Age of 15 Years With Leukemia: Temporal Patterns in Eastern and Western Germany Since German Reunification. Hemasphere. August 2022;6(8):e755.
  149. Weilert H, Sadeghi D, Lipp M, Oldhafer KJ, Donati M, Stang A. Potential for cure and predictors of long-term survival after radiofrequency ablation for colorectal liver metastases: A 20-years single-center experience. Eur J Surg Oncol. Dezember 2022;48(12):2487-94.
  150. Wang X, Chen H, Middha Kapoor P, Su YR, Bolla MK, Dennis J, u. a. A genome-wide gene-based gene-environment interaction study of breast cancer in more than 90,000 women. Cancer Res Commun. April 2022;2(4):211-9.
  151. Völkel V, Schatz S, Draeger T, Gerken M, Klinkhammer-Schalke M, Fürst A. Transanal total mesorectal excision: short- and long-term results of the first hundred cases of a certified colorectal cancer center in Germany. Surg Endosc. Februar 2022;36(2):1172-80.
  152. Voigtländer S, Hakimhashemi A, Grundmann N, Rees F, Meyer M, Algül H, u. a. Trends of colorectal cancer incidence according to age, anatomic site, and histological subgroup in Bavaria: A registry-based study. Front Oncol. 2022;12:904546.
  153. Voigtländer S, Hakimhashemi A, Grundmann N, Meyer M, Müller-Nordhorn J. Comparison of trends in early-onset colorectal cancer in North America and Europe. Lancet Gastroenterol Hepatol. Juni 2022;7(6):505-6.
  154. Vener C, Rossi S, Minicozzi P, Marcos-Gragera R, Poirel HA, Maynadié M, u. a. Clear Improvement in Real-World Chronic Myeloid Leukemia Survival: A Comparison With Randomized Controlled Trials. Front Oncol. 2022;12:892684.
  155. Vehling S, Mehnert-Theuerkauf A, Philipp R, Härter M, Kraywinkel K, Kuhnert R, u. a. Prevalence of mental disorders in patients with cancer compared to matched controls - secondary analysis of two nationally representative surveys. Acta Oncol. Januar 2022;61(1):7-13.
  156. Trocchi P, Mach P, Kimmig KR, Stang A. Ovarian cancer surgery in Germany: An analysis of the nationwide hospital file 2005-2015. Womens Health (Lond). Dezember 2022;18:17455065221075903.
  157. Trama A, Bernasconi A, Botta L, Byrne J, Grabow D, Reulen RC, u. a. Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort. Pediatr Blood Cancer. Dezember 2022;69(12):e29991.
  158. Tian Y, Kim AE, Bien SA, Lin Y, Qu C, Harrison TA, u. a. Genome-Wide Interaction Analysis of Genetic Variants With Menopausal Hormone Therapy for Colorectal Cancer Risk. J Natl Cancer Inst. 8. August 2022;114(8):1135-48.
  159. Thong MSY, van Noorden CJF, Steindorf K, Arndt V. Correction to: Cancer-Related Fatigue: Causes and Current Treatment Options. Curr Treat Options Oncol. März 2022;23(3):450-1.
  160. Thong MSY, Doege D, Weißer L, Koch-Gallenkamp L, Bertram H, Eberle A, u. a. Health and life insurance-related problems in very long-term cancer survivors in Germany: a population-based study. J Cancer Res Clin Oncol. Januar 2022;148(1):155-62.
  161. Teufel A, Li M, Gerken M, Ebert MP, Schlitt HJ, Evert M, u. a. Second Cancer After Additive Chemotherapy in Patients With Colon Cancer. Clin Colorectal Cancer. Dezember 2022;21(4):354-61.
  162. Tanoey J, Baechle C, Brenner H, Deckert A, Fricke J, Günther K, u. a. Birth Order, Caesarean Section, or Daycare Attendance in Relation to Child- and Adult-Onset Type 1 Diabetes: Results from the German National Cohort. Int J Environ Res Public Health. 31. August 2022;19(17).
  163. Stürzl R, Gerken M, Bruns C, Klinkhammer-Schalke M, Pauer A, Piso P. [Surgical treatment of adenocarcinoma of the esophagogastric junction type II‚ÄĮ: Comparison between transhiatal extended gastrectomy and thoracoabdominal esophagectomy]. Chirurgie (Heidelb). November 2022;93(11):1072-81.
  164. Struck JP, Schnoor M, Schulze A, Hupe MC, Ozimek T, Oppolzer IA, u. a. Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals. World J Urol. Februar 2022;40(2):409-18.
  165. Sternjakob-Marthaler A, Berk√≥-Göttel B, Rissland J, Schöpe J, Taurian E, Müller H, u. a. Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates. PLoS One. 2022;17(9):e0273332.
  166. Stang A, Wellmann I, Holleczek B, Fell B, Terner S, Lutz MP, u. a. Incidence and relative survival of pancreatic adenocarcinoma and pancreatic neuroendocrine neoplasms in Germany, 2009-2018. An in-depth analysis of two population-based cancer registries. Cancer Epidemiol. August 2022;79:102204.
  167. Stang A, Schuldt K, Trocchi P, Neusser S, Speckemeier C, Pahmeier K, u. a. The impossibility of mortality evaluation of skin cancer screening in Germany based on health insurance data: a case-control study. Eur J Cancer. September 2022;173:52-8.
  168. Stang A, Schmidt B. Reporting of Statistical Inference in Abstracts of Major Cancer Journals, 1990 to 2020. JAMA Netw Open. 1. Juni 2022;5(6):e2218337.
  169. Stang A. Cancer Mortality in Hamburg (Germany) 1872-2019. Dtsch Arztebl Int. 28. Januar 2022;119(4):41-6.
  170. Ssenyonga N, Stiller C, Nakata K, Shalkow J, Redmond S, Bulliard JL, u. a. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries. Lancet Child Adolesc Health. Juni 2022;6(6):409-31.
  171. Spoerl S, Spoerl S, Reil S, Gerken M, Ludwig N, Taxis J, u. a. Prognostic Value of Perineural Invasion on Survival and Recurrence in Oral Squamous Cell Carcinoma. Diagnostics (Basel). 24. April 2022;12(5).
  172. Spoerl S, Gerken M, Chamilos C, Spoerl S, Fischer R, Vielsmeier V, u. a. Clinical significance of panendoscopy in initial staging of oral squamous cell carcinoma and detection of synchronous second malignancies of the upper aerodigestive tract - Insights from a retrospective population-based cohort study. J Craniomaxillofac Surg. Juni 2022;50(6):515-22.
  173. Speckemeier C, Pahmeier K, Trocchi P, Schuldt K, Lax H, Nonnemacher M, u. a. One-year follow-up healthcare costs of patients diagnosed with skin cancer in Germany: a claims data analysis. BMC Health Serv Res. 11. Juni 2022;22(1):771.
  174. Shan L, Zhang L, Zhu X, Wang Z, Fang S, Lin J, u. a. Chinese never smokers with adenocarcinoma of the lung are younger and have fewer lymph node metastases than smokers. Respir Res. 29. Oktober 2022;23(1):293.
  175. Schüz J, Borkhardt A, Bouaoun L, Erdmann F. The impact of the COVID-19 pandemic on the future incidence of acute lymphoblastic leukaemia in children: Projections for Germany under a COVID-19 related scenario. Int J Cancer. 1. Juli 2022;151(1):153-5.
  176. Schmutzler RK, Schmitz-Luhn B, Borisch B, Devilee P, Eccles D, Hall P, u. a. Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors. Breast Care (Basel). April 2022;17(2):208-23.
  177. Schmidt ME, Goldschmidt S, Hermann S, Steindorf K. Late effects, long-term problems and unmet needs of cancer survivors. Int J Cancer. 15. Oktober 2022;151(8):1280-90.
  178. Schleicher O, Horndasch A, Krumbholz M, Sembill S, Bremensdorfer C, Grabow D, u. a. Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia. Front Oncol. 2022;12:963223.
  179. Schleicher O, Horndasch A, Krumbholz M, Sembill S, Bremensdorfer C, Grabow D, u. a. Corrigendum: Patient-reported long-term outcome following allogeneic hematopoietic stem cell transplantation in pediatric chronic myeloid leukemia. Front Oncol. 2022;12:1116757.
  180. Schirrmacher R, Rieger B, Justenhoven C. [Treatment in Certified Centres (DKG): Decision Factors of Lung Cancer Patients]. Pneumologie. August 2022;76(8):547-51.
  181. Scherer-Trame S, Jansen L, Koch-Gallenkamp L, Arndt V, Chang-Claude J, Hoffmeister M, u. a. Quality of life, distress, and posttraumatic growth 5 years after colorectal cancer diagnosis according to history of inpatient rehabilitation. J Cancer Res Clin Oncol. November 2022;148(11):3015-28.
  182. Scharl S, Sprötge T, Gerken M, Scharl A, Ignatov A, Inwald EC, u. a. Factors influencing treatment decision and guideline conformity in high-grade endometrial cancer patients: a population-based study. Arch Gynecol Obstet. Januar 2022;305(1):203-13.
  183. Sahm M, Schneider C, Gretschel S, Kube R, Becker A, Günther M, u. a. [Reality of care of colorectal cancer in the State of Brandenburg‚ÄĮ: With special consideration of the number of hospital cases and certification as a colorectal cancer center]. Chirurg. März 2022;93(3):274-85.
  184. Sachs B, Dubrall D, Kraywinkel K, Schulz M, Schmid M, Bate J, u. a. Descriptive analysis of 179 German reports of melanoma reported to an adverse drug reaction database as a drug-related adverse effect, and comparison with melanoma cases contained in German cancer registries. Clin Exp Dermatol. Juni 2022;47(6):1078-87.
  185. Röhrmoser K, Ignatov A, Gerken M, Ortmann O, Klinkhammer-Schalke M, Papathemelis T. Risk factors and temporal patterns of recurrences in patients with vulvar cancer: implications for follow-up intervals and duration. J Cancer Res Clin Oncol. 18. Februar 2022;
  186. Roessler M, Schmitt J, Bobeth C, Gerken M, Kleihues-van Tol K, Reissfelder C, u. a. Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study. BMC Cancer. 7. Juni 2022;22(1):621.
  187. Pokora RM, Büttner M, Schulz A, Schuster AK, Merzenich H, Teifke A, u. a. Determinants of mammography screening participation-a cross-sectional analysis of the German population-based Gutenberg Health Study (GHS). PLoS One. 2022;17(10):e0275525.
  188. Pigeot I, Bongaerts B, Eberle A, Katalinic A, Kieschke J, Luttmann S, u. a. [Linkage of claims data with data from epidemiological cancer registries: possibilities and limitations in the German federal states]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Mai 2022;65(5):615-23.
  189. Peters A, Peters A, Greiser KH, Göttlicher S, Ahrens W, Albrecht M, u. a. Framework and baseline examination of the German National Cohort (NAKO). Eur J Epidemiol. Oktober 2022;37(10):1107-24.
  190. Perna L, Trares K, Perneczky R, Tato M, Stocker H, Möllers T, u. a. Risk of Late-Onset Depression and Cognitive Decline: Results From Inflammatory Proteome Analyses in a Prospective Population-Based Cohort Study. Am J Geriatr Psychiatry. Juni 2022;30(6):689-700.
  191. Onyije FM, Olsson A, Baaken D, Erdmann F, Stanulla M, Wollschläger D, u. a. Environmental Risk Factors for Childhood Acute Lymphoblastic Leukemia: An Umbrella Review. Cancers (Basel). 13. Januar 2022;14(2).
  192. Oesterling F, Kajüter H, Nachtsheim L, Löning T, Stang A. Letter: Parotid gland metastases of cutaneous squamous cell carcinoma - a corroboration at population level. Head Neck Pathol. September 2022;16(3):836-7.
  193. NikŇ°ińá M, Matz M, Valkov M, Marcos-Gragera R, Stiller C, Rosso S, u. a. World-wide trends in net survival from pancreatic cancer by morphological sub-type: An analysis of 1,258,329 adults diagnosed in 58 countries during 2000-2014 (CONCORD-3). Cancer Epidemiol. Oktober 2022;80:102196.
  194. Nguyen TNM, Sha S, Chen LJ, Holleczek B, Brenner H, Schöttker B. Strongly increased risk of gastric and duodenal ulcers among new users of low-dose aspirin: results from two large cohorts with new-user design. Aliment Pharmacol Ther. Juli 2022;56(2):251-62.
  195. Nguyen TNM, Chen LJ, Trares K, Stocker H, Holleczek B, Beyreuther K, u. a. Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer's disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies. Alzheimers Res Ther. 28. Mai 2022;14(1):75.
  196. Mor JM, Rokohl AC, Dahm S, Kraywinkel K, Heindl LM. Epidemiology of uveal melanomas in Germany. Acta Ophthalmol. Dezember 2022;100(8):e1774-5.
  197. Möllers T, Stocker H, Perna L, Rujescu D, Holleczek B, Schöttker B, u. a. Subjective short-term memory difficulties at ages 50-75 predict dementia risk in a community-based cohort followed over 17 years. Age Ageing. 1. Juni 2022;51(6):afac113.
  198. Merzenich H, Baaken D, Schneider A, Neu MA, Wingerter A, Faber J, u. a. Mortality risk among 5-year survivors of childhood cancer in Germany-Results from the CVSS study (Cardiac and Vascular late Sequelae in long-term Survivors of childhood cancer study). Int J Cancer. 1. Januar 2022;150(1):67-72.
  199. Markeeva-Ilisevic E, Holleczek B, Becher H, Winkler V. Non-melanoma skin cancer among ethnic German immigrants (resettler) from the former Soviet Union: a cohort study from 1990 to 2007. Arch Public Health. 18. März 2022;80(1):85.
  200. Mantke R, Schneider C, Weylandt K, Gretschel S, Marusch F, Kube R, u. a. [Epidemiology and surgical treatment of pancreatic cancer in the State of Brandenburg‚ÄĮ: Analysis of 5418 cases]. Chirurgie (Heidelb). August 2022;93(8):788-801.
  201. Lohse S, Sternjakob-Marthaler A, Lagemann P, Schöpe J, Rissland J, Seiwert N, u. a. German federal-state-wide seroprevalence study of 1(st) SARS-CoV-2 pandemic wave shows importance of long-term antibody test performance. Commun Med (Lond). 2022;2:52.
  202. Liang LA, Zeissig SR, Schauberger G, Merzweiler S, Radde K, Fischbeck S, u. a. Colposcopy non-attendance following an abnormal cervical cancer screening result: a prospective population-based cohort study. BMC Womens Health. 9. Juli 2022;22(1):285.
  203. Li X, Schöttker B, Holleczek B, Brenner H. Associations of DNA methylation algorithms of aging and cancer risk: Results from a prospective cohort study. EBioMedicine. Juli 2022;81:104083.
  204. Li X, Schöttker B, Holleczek B, Brenner H. Association of longitudinal repeated measurements of frailty index with mortality: Cohort study among community-dwelling older adults. EClinicalMedicine. November 2022;53:101630.
  205. Li X, Delerue T, Schöttker B, Holleczek B, Grill E, Peters A, u. a. Derivation and validation of an epigenetic frailty risk score in population-based cohorts of older adults. Nat Commun. 7. September 2022;13(1):5269.
  206. Kuss O, Becher H, Wienke A, Ittermann T, Ostrzinski S, Schipf S, u. a. Statistical Analysis in the German National Cohort (NAKO) - Specific Aspects and General Recommendations. Eur J Epidemiol. April 2022;37(4):429-36.
  207. Kube SJ, Blattmann C, Bielack SS, Kager L, Kaatsch P, Kühne T, u. a. Secondary malignant neoplasms after bone and soft tissue sarcomas in children, adolescents, and young adults. Cancer. 1. Mai 2022;128(9):1787-800.
  208. Köngeter A, Schickhardt C, Jungkunz M, Bergbold S, Mehlis K, Winkler EC. Patients' Willingness to Provide Their Clinical Data for Research Purposes and Acceptance of Different Consent Models: Findings From a Representative Survey of Patients With Cancer. J Med Internet Res. 25. August 2022;24(8):e37665.
  209. Kollhorst B, Reinders T, Grill S, Eberle A, Intemann T, Kieschke J, u. a. Record linkage of claims and cancer registries data-Evaluation of a deterministic linkage approach based on indirect personal identifiers. Pharmacoepidemiol Drug Saf. Dezember 2022;31(12):1287-93.
  210. Kist M, Thomaschewski M, Keck Y, Abdalla TSA, Zeissig SR, Kleihues-van Tol K, u. a. Specifics of Young Gastric Cancer Patients: A Population-Based Analysis of 46,110 Patients with Gastric Cancer from the German Clinical Cancer Registry Group. Cancers (Basel). 30. November 2022;14(23).
  211. Kendzia B, Kaerlev L, Ahrens W, Merletti F, Eriksson M, Guénel P, u. a. Lifetime Exposure to Welding Fumes and Risk of Some Rare Cancers. Am J Epidemiol. 28. September 2022;191(10):1753-65.
  212. Kaatsch P, Trübenbach C, Kaiser M, Erdmann F, Spix C, Grabow D. [The 41,000 long-term survivor cohort of the German Childhood Cancer Registry]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. April 2022;65(4):453-61.
  213. Justenhoven C, Rieger B. The Impact of the Corona Pandemic on Reported Data Relating to Cancer Diagnoses, Therapy, and Follow-Up. Dtsch Arztebl Int. 21. Oktober 2022;119(42):724-5.
  214. Jung AY, Ahearn TU, Behrens S, Middha P, Bolla MK, Wang Q, u. a. Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies. J Natl Cancer Inst. 8. Dezember 2022;114(12):1706-19.
  215. Juhnke BO, Gessi M, Gerber NU, Friedrich C, Mynarek M, von Bueren AO, u. a. Treatment of embryonal tumors with multilayered rosettes with carboplatin/etoposide induction and high-dose chemotherapy within the prospective P-HIT trial. Neuro Oncol. 5. Januar 2022;24(1):127-37.
  216. Jordahl KM, Shcherbina A, Kim AE, Su YR, Lin Y, Wang J, u. a. Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region. Cancer Epidemiol Biomarkers Prev. 4. Mai 2022;31(5):1077-89.
  217. Hippert F, Desing L, Diez S, Witowski A, Bernbeck B, Abele M, u. a. Rare Tumors in Children and Adolescents - the STEP Working Group's Evolution to a Prospective Registry. Klin Padiatr. Mai 2022;234(3):146-53.
  218. Hartlapp I, Valta-Seufzer D, Siveke JT, Algül H, Goekkurt E, Siegler G, u. a. Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113). ESMO Open. August 2022;7(4):100552.
  219. Grandt CL, Brackmann LK, Poplawski A, Schwarz H, Hummel-Bartenschlager W, Hankeln T, u. a. Radiation-response in primary fibroblasts of long-term survivors of childhood cancer with and without second primary neoplasms: the KiKme study. Mol Med. 6. September 2022;28(1):105.
  220. Gorski M, Rasheed H, Teumer A, Thomas LF, Graham SE, Sveinbjornsson G, u. a. Genetic loci and prioritization of genes for kidney function decline derived from a meta-analysis of 62 longitudinal genome-wide association studies. Kidney Int. September 2022;102(3):624-39.
  221. Gennari P, Tchaikovski S, Mész√°ros J, Gerken M, Klinkhammer-Schalke M, Toth G, u. a. Protective effect of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer. Gynecol Oncol. Juli 2022;166(1):57-60.
  222. Gaziano L, Sun L, Arnold M, Bell S, Cho K, Kaptoge SK, u. a. Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses. Circulation. 15. November 2022;146(20):1507-17.
  223. Gao X, Huang N, Jiang M, Holleczek B, Schöttker B, Huang T, u. a. Mortality and morbidity risk prediction for older former smokers based on a score of smoking history: evidence from UK Biobank and ESTHER cohorts. Age Ageing. 1. Juli 2022;51(7):afac154.
  224. Gambichler T, Stang A, Mansour R, Scheel CH, Nick C, Abu Rached N, u. a. Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients. Cancers (Basel). 11. September 2022;14(18).
  225. Galetzka D, Böck J, Wagner L, Dittrich M, Sinizyn O, Ludwig M, u. a. Hypermethylation of RAD9A intron 2 in childhood cancer patients, leukemia and tumor cell lines suggest a role for oncogenic transformation. EXCLI J. 2022;21:117-43.
  226. Gaisser A, Eckford RD, Arndt V, Doege D, Kludt E, Ubels J, u. a. [Nearly two years of the coronavirus pandemic from the perspective of people affected by cancer]. Onkologe (Berl). 2022;28(3):248-52.
  227. Forster F, Herrera R, Hoopmann M, Kieschke J, Deitermann B, Radon K. Residential proximity to oil and gas production sites and hematologic malignancies: A case-control study. Am J Ind Med. Dezember 2022;65(12):985-93.
  228. Fochler S, Weitmann K, Domin M, Hoffmann W. Reasons for Non-Attendance in the German National Mammography Screening Program: Which Barriers Can Be Overcome Using Telephone Counseling?-A Randomized Controlled Trial. Healthcare (Basel). 21. Dezember 2022;11(1).
  229. Flegar L, Kraywinkel K, Zacharis A, Aksoy C, Koch R, Eisenmenger N, u. a. Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2019. World J Urol. Juli 2022;40(7):1715-21.
  230. Filippini Vel√°zquez G, Schiele S, Gerken M, Neumaier S, Hackl C, Mayr P, u. a. Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancer. ESMO Open. Juni 2022;7(3):100470.
  231. Fante MA, Felsenstein M, Mayer S, Gerken M, Klinkhammer-Schalke M, Herr W, u. a. All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma. Front Oncol. 2022;12:852987.
  232. Eyl-Armbruster RE, Thong MSY, Carr PR, Jansen L, Chang-Claude J, Hoffmeister M, u. a. Change Toward Healthier Lifestyles Is Associated With Better Health-Related Quality of Life in Long-Term Colorectal Cancer Survivors. J Natl Compr Canc Netw. November 2022;20(11):1233-1243.e10.
  233. Ernst M, Brähler E, Faber J, Wild PS, Merzenich H, Beutel ME. A Mixed-Methods Investigation of Medical Follow-Up in Long-Term Childhood Cancer Survivors: What Are the Reasons for Non-Attendance? Front Psychol. 2022;13:846671.
  234. Erdmann F, Spix C, Schrappe M, Borkhardt A, Schüz J. Temporal changes of the incidence of childhood cancer in Germany during the COVID-19 pandemic: Updated analyses from the German Childhood Cancer Registry. Lancet Reg Health Eur. Juni 2022;17:100398.
  235. Eichberger J, Weber F, Spanier G, Gerken M, Schreml S, Schulz D, u. a. Loss of MMP-27 Predicts Mandibular Bone Invasion in Oral Squamous Cell Carcinoma. Cancers (Basel). 22. August 2022;14(16).
  236. Eberl M, Tanaka LF, Kraywinkel K, Klug SJ. Incidence of Smoking-Related Second Primary Cancers After Lung Cancer in Germany: An Analysis of Nationwide Cancer Registry Data. J Thorac Oncol. März 2022;17(3):388-98.
  237. Dutzmann CM, Spix C, Popp I, Kaiser M, Erdmann F, Erlacher M, u. a. Cancer in Children With Fanconi Anemia and Ataxia-Telangiectasia-A Nationwide Register-Based Cohort Study in Germany. J Clin Oncol. 1. Januar 2022;40(1):32-9.
  238. Doege D, Thong MSY, Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, u. a. Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors. J Cancer Res Clin Oncol. Dezember 2022;148(12):3461-73.
  239. Dixon-Suen SC, Lewis SJ, Martin RM, English DR, Boyle T, Giles GG, u. a. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. Br J Sports Med. Oktober 2022;56(20):1157-70.
  240. Di Carlo V, Stiller CA, Eisemann N, Bordoni A, Matz M, Curado MP, u. a. Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1‚Ää578‚Ää482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3). Br J Dermatol. September 2022;187(3):364-80.
  241. Dennis J, Tyrer JP, Walker LC, Michailidou K, Dorling L, Bolla MK, u. a. Rare germline copy number variants (CNVs) and breast cancer risk. Commun Biol. 18. Januar 2022;5(1):65.
  242. Deichmann S, Dworschak O, Kulemann B, Höppner J, Bolm L, Klinkhammer-Schalke M, u. a. [Incidence, Treatment and Survival in Pancreatic Cancer- Data of the Nationwide Oncological Quality Conference from a Surgical Perspective]. Zentralbl Chir. April 2022;147(2):147-54.
  243. Clausen S, Falk M, Oesterling F, Fehr A, Stang A, Boecker W, u. a. Outcome of Ordinary Polymorphous Adenocarcinomas of the Salivary Glands in Comparison With Papillary and Cribriform Subtypes. Anticancer Res. März 2022;42(3):1455-63.
  244. Chronaki C, Charalambous E, Cangioli G, Schreier G, van den Oever S, van der Pal H, u. a. Factors Influencing Implementation of the Survivorship Passport: The IT Perspective. Stud Health Technol Inform. 16. Mai 2022;293:161-8.
  245. Camargo MC, Song M, Xu X, Zhao I, Sampson JN, Etemadi A, u. a. Urinary estrogen metabolites and gastric cancer risk among postmenopausal women. Cancer Rep (Hoboken). Juli 2022;5(7):e1574.
  246. Cabasag CJ, Vignat J, Ferlay J, Arndt V, Lemmens V, Praagman J, u. a. The preventability of cancer in Europe: A quantitative assessment of avoidable cancer cases across 17 cancer sites and 38 countries in 2020. Eur J Cancer. Dezember 2022;177:15-24.
  247. Byrne J, Schmidtmann I, Rashid H, Hagberg O, Bagnasco F, Bardi E, u. a. Impact of era of diagnosis on cause-specific late mortality among 77‚ÄČ423 five-year European survivors of childhood and adolescent cancer: The PanCareSurFup consortium. Int J Cancer. 1. Februar 2022;150(3):406-19.
  248. Bundred JR, Michael S, Stuart B, Cutress RI, Beckmann K, Holleczek B, u. a. Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis. BMJ. 21. September 2022;378:e070346.
  249. Brenner H, Cardoso R, Heisser T, Hoffmeister M, Holleczek B. Indications of substantial delay of colorectal cancer diagnoses due to COVID-19 in Germany. Lancet Reg Health Eur. Dezember 2022;23:100543.
  250. Braun R, Klinkhammer-Schalke M, Zeissig SR, Kleihues-van Tol K, Bolm L, Honselmann KC, u. a. Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma-Results from the German Cancer Registry Group. Cancers (Basel). 16. August 2022;14(16).
  251. Brackmann LK, Foraita R, Schwarz H, Galetzka D, Zahnreich S, Hankeln T, u. a. Late health effects and changes in lifestyle factors after cancer in childhood with and without subsequent second primary cancers - the KiKme case-control study. Front Oncol. 2022;12:1037276.
  252. Botta L, Gatta G, Capocaccia R, Stiller C, Ca√Īete A, Dal Maso L, u. a. Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study. Lancet Oncol. Dezember 2022;23(12):1525-36.
  253. Borkhardt A, Schüz J, Trübenbach C, Wellbrock M, Spix C, Erdmann F. Temporal changes of the incidence of childhood B-cell precursor acute lymphoblastic leukaemia in Germany during the COVID-19 pandemic. Leukemia. Dezember 2022;36(12):2908-11.
  254. Bolm L, Zemskov S, Zeller M, Baba T, Roldan J, Harrison JM, u. a. Concepts and Outcomes of Perioperative Therapy in Stage IA-III Pancreatic Cancer-A Cross-Validation of the National Cancer Database (NCDB) and the German Cancer Registry Group of the Society of German Tumor Centers (GCRG/ADT). Cancers (Basel). 9. Februar 2022;14(4).
  255. Bhardwaj M, Schöttker B, Holleczek B, Benner A, Schrotz-King P, Brenner H. Potential of Inflammatory Protein Signatures for Enhanced Selection of People for Lung Cancer Screening. Cancers (Basel). 26. April 2022;14(9).
  256. Bhardwaj M, Schöttker B, Holleczek B, Brenner H. Comparison of discrimination performance of 11 lung cancer risk models for predicting lung cancer in a prospective cohort of screening-age adults from Germany followed over 17 years. Lung Cancer. Dezember 2022;174:83-90.
  257. Beyer L, Stocker H, Rujescu D, Holleczek B, Stockmann J, Nabers A, u. a. Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years. Alzheimers Dement. 19. Juli 2022;
  258. Betzmann D, Döring M, Blumenstock G, Erdmann F, Grabow D, Lang P, u. a. Impact of Serum Insulin-Like Growth Factor 1 on Hematopoietic Stem Cell Transplantation Outcome in Pediatric Cancer Patients. Transplant Cell Ther. Juli 2022;28(7):355.e1-355.e9.
  259. Armbrust R, Ledwon P, Von Rüsten A, Schneider C, Sehouli J. Primary Treatment Results in Patients with Ovarian, Fallopian or Peritoneal Cancer-Results of a Clinical Cancer Registry Database Analysis in Germany. Cancers (Basel). 24. September 2022;14(19).
  260. Aleshchenko E, Swart E, Spix C, Voigt M, Trocchi P, Langer T, u. a. Long-term care, care needs and wellbeing of individuals after cancer in childhood or adolescence (VersKiK): study protocol of a large scale multi-methods non-interventional study. BMC Health Serv Res. 20. September 2022;22(1):1176.
  261. Ahearn TU, Zhang H, Michailidou K, Milne RL, Bolla MK, Dennis J, u. a. Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Res. 4. Januar 2022;24(1):2.
  262. Acs M, Halmy L, Isgandarova S, Blaj S, Gerken M, Hormann B, u. a. Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre. Anticancer Res. Februar 2022;42(2):1019-29.
  263. Acs M, Gerken M, Gajic I, Mayr M, Zustin J, Piso P. Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbecks Arch Surg. November 2022;407(7):3057-67.
  264. Achajew A, Brecht IB, Radespiel-Tröger M, Meyer M, Metzler M, Bremensdorfer C, u. a. Rare pediatric tumors in Germany - not as rare as expected: a study based on data from the Bavarian Cancer Registry and the German Childhood Cancer Registry. Eur J Pediatr. Juli 2022;181(7):2723-30.
  265. Abele M, Voggel S, Bremensdorfer C, Spix C, Erdmann F, Kuhlen M, u. a. Incidences and characteristics of primary lung malignancies in childhood in Germany: An analysis of population-based data from German cancer registries. Pediatr Blood Cancer. September 2022;69(9):e29744.
  266. Windschüttl S, Pukrop T, Herrmann A, Lindberg-Scharf P, Heudobler D, Herr W, u. a. [Development of a screening workflow to identify patient needs in an interdisciplinary oncological day clinic]. Z Evid Fortbild Qual Gesundhwes. Juni 2021;163:30-7.
  267. Waldmann A, Hübner J, Katalinic A. Trends Over Time in Breast-Cancer-Specific Mortality in Germany. Dtsch Arztebl Int. 9. August 2021;118(31-32):538-9.
  268. Völkel V, Klinkhammer-Schalke M, Fürst A. Falling Mortality Thanks to Improved Treatment for Colorectal Cancer. Dtsch Arztebl Int. 1. Oktober 2021;118(39):664.
  269. Voigtländer S, Hakimhashemi A, Inwald EC, Ortmann O, Gerken M, Klug SJ, u. a. The Impact of the COVID-19 Pandemic on Cancer Incidence and Treatment by Cancer Stage in Bavaria, Germany. Dtsch Arztebl Int. 1. Oktober 2021;118(39):660-1.
  270. Staubach P, Scharl A, Ignatov A, Ortmann O, Inwald EC, Hildebrandt T, u. a. Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM(¬ģ) fluorescence camera: a comparison between primary sentinel lymph node biopsy versus sentinel lymph node biopsy after neoadjuvant chemotherapy. J Cancer Res Clin Oncol. Juni 2021;147(6):1813-23.
  271. Spoerl S, Spanier G, Reiter E, Gerken M, Haferkamp S, Grosse J, u. a. Head and neck melanoma: outcome and predictors in a population-based cohort study. Head Face Med. 22. Oktober 2021;17(1):45.
  272. Spoerl S, Gerken M, Mamilos A, Fischer R, Wolf S, Nieberle F, u. a. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study. Clin Oral Investig. April 2021;25(4):1705-13.
  273. Spanier G, Ugele I, Nieberle F, Symeou L, Schmidhofer S, Brand A, u. a. The predictive power of CD3(+) T cell infiltration of oral squamous cell tumors is limited to non-diabetic patients. Cancer Lett. 28. Februar 2021;499:209-19.
  274. Schmidt ME, Bergbold S, Hermann S, Steindorf K. Knowledge, perceptions, and management of cancer-related fatigue: the patients' perspective. Support Care Cancer. April 2021;29(4):2063-71.
  275. Scheel K, Franke T, Weikert A, Dick M, Walter A, Zeidler J, u. a. Record Linkage in Clinical Cancer Registration: Experiences and Findings from Lower Saxony. Stud Health Technol Inform. 24. Mai 2021;278:101-9.
  276. Scharl S, Gerken M, Sprötge T, Kronberger K, Scharl A, Ignatov A, u. a. Comparison of survival outcomes and effects of therapy between subtypes of high-grade endometrial cancer - a population-based study. Acta Oncol. Juli 2021;60(7):897-903.
  277. Scharl S, Becher C, Gerken M, Scharl A, Anapolski M, Ignatov A, u. a. Is there a benefit for adjuvant radio(chemo)therapy in early cervical cancer? Results from a population-based study. Arch Gynecol Obstet. September 2021;304(3):759-71.
  278. Sacchetto L, Rosso S, Comber H, Bouchardy C, Broganelli P, Galceran J, u. a. Skin melanoma deaths within 1 or 3‚ÄČyears from diagnosis in Europe. Int J Cancer. 15. Juni 2021;148(12):2898-905.
  279. Rudolph CES, Engholm G, Pritzkuleit R, Storm HH, Katalinic A. Survival of breast cancer patients in German-Danish border regions - A registry-based cohort study. Cancer Epidemiol. Oktober 2021;74:102001.
  280. Pruessmann J, Pursche T, Hammersen F, Katalinic A, Fischer D, Waldmann A. Conditional Disease-Free and Overall Survival of 1,858 Young Women with Non-Metastatic Breast Cancer and with Participation in a Post-Therapeutic Rehab Programme according to Clinical Subtypes. Breast Care (Basel). April 2021;16(2):163-72.
  281. Petrova E, Wellner J, Nording AK, Braun R, Honselmann KC, Bolm L, u. a. Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group. Cancers (Basel). 4. Dezember 2021;13(23).
  282. Markowiak T, Neu R, Ansari MKA, Großer C, Klinkhammer-Schalke M, Hofmann HS, u. a. Surgical Cytoreduction and HITOC for Thymic Malignancies with Pleural Dissemination. Thorac Cardiovasc Surg. März 2021;69(2):157-64.
  283. Markowiak T, Dakkak B, Loch E, Großer C, Klinkhammer-Schalke M, Hofmann HS, u. a. Video-assisted pulmonary metastectomy is equivalent to thoracotomy regarding resection status and survival. J Cardiothorac Surg. 15. April 2021;16(1):84.
  284. Liu Z, Thong MSY, Doege D, Koch-Gallenkamp L, Bertram H, Eberle A, u. a. Prevalence of benefit finding and posttraumatic growth in long-term cancer survivors: results from a multi-regional population-based survey in Germany. Br J Cancer. September 2021;125(6):877-83.
  285. Liu Z, Doege D, Thong MSY, Koch-Gallenkamp L, Bertram H, Eberle A, u. a. Distress mediates the relationship between cognitive appraisal of medical care and benefit finding/posttraumatic growth in long-term cancer survivors. Cancer. 1. Oktober 2021;127(19):3680-90.
  286. Lindberg-Scharf P, Steinger B, Koller M, Hofstädter A, Ortmann O, Kurz J, u. a. Long-term improvement of quality of life in patients with breast cancer: supporting patient-physician communication by an electronic tool for inpatient and outpatient care. Support Care Cancer. Dezember 2021;29(12):7865-75.
  287. Lillini R, Tittarelli A, Bertoldi M, Ritchie D, Katalinic A, Pritzkuleit R, u. a. Water and Soil Pollution: Ecological Environmental Study Methodologies Useful for Public Health Projects. A Literature Review. Rev Environ Contam Toxicol. 2021;256:179-214.
  288. Krensel M, Petersen J, Stephan B, Katalinic A, Augustin J. Comparison of patient pathways in the early detection of skin cancer - a claims data analysis. J Dtsch Dermatol Ges. März 2021;19(3):389-98.
  289. Keim U, Gandini S, Amaral T, Katalinic A, Holleczek B, Flatz L, u. a. Cutaneous melanoma attributable to UVR exposure in Denmark and Germany. Eur J Cancer. Dezember 2021;159:98-104.
  290. Jansen L, Kanbach J, Finke I, Arndt V, Emrich K, Holleczek B, u. a. Estimation of the Potentially Avoidable Excess Deaths Associated with Socioeconomic Inequalities in Cancer Survival in Germany. Cancers (Basel). 19. Januar 2021;13(2).
  291. Jansen L, Erb C, Nennecke A, Finke I, Pritzkuleit R, Holleczek B, u. a. Socioeconomic deprivation and cancer survival in a metropolitan area: An analysis of cancer registry data from Hamburg, Germany. Lancet Reg Health Eur. Mai 2021;4:100063.
  292. Hübner J, Mattutat J, Katalinic A. [Years of life lost: known methods and a refined approach using the example of the most frequent causes of death in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. November 2021;64(11):1463-72.
  293. Hetterich M, Gerken M, Ortmann O, Inwald EC, Klinkhammer-Schalke M, Eggemann H, u. a. Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases. Breast Cancer Res Treat. Juni 2021;187(3):715-27.
  294. Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. Psychosocial and family-centered support among breast cancer patients with dependent children. Psychooncology. März 2021;30(3):361-8.
  295. Gonz√°lez Maldonado S, Motsch E, Trotter A, Kauczor HU, Heussel CP, Hermann S, u. a. Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial. Int J Cancer. 1. März 2021;148(5):1097-105.
  296. Girardi F, Rous B, Stiller CA, Gatta G, Fersht N, Storm HH, u. a. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3). Neuro Oncol. 1. Oktober 2021;23(10):1765-76.
  297. Gieseler F, Heidenreich A, Schubert J, Frielitz F, Rehmann-Sutter C, Wörler F, u. a. The role of family confidants and caregivers in the care of older cancer patients: Extending the concept of "shared decision-making". Health Sci Rep. Juni 2021;4(2):e281.
  298. Gennari P, Gerken M, Mész√°ros J, Klinkhammer-Schalke M, Ortmann O, Eggemann H, u. a. Minimal-invasive or open approach for surgery of early cervical cancer: the treatment center matters. Arch Gynecol Obstet. August 2021;304(2):503-10.
  299. Garbe C, Keim U, Gandini S, Amaral T, Katalinic A, Hollezcek B, u. a. Epidemiology of cutaneous melanoma and keratinocyte cancer in white populations 1943-2036. Eur J Cancer. Juli 2021;152:18-25.
  300. Finke I, Behrens G, Maier W, Schwettmann L, Pritzkuleit R, Holleczek B, u. a. Small-area analysis on socioeconomic inequalities in cancer survival for 25 cancer sites in Germany. Int J Cancer. 1. August 2021;149(3):561-72.
  301. Elsner SA, Salek SS, Finlay AY, Hagemeier A, Bottomley CJ, Katalinic A, u. a. Validation of the German version of the Family Reported Outcome Measure (FROM-16) to assess the impact of disease on the partner or family member. Health Qual Life Outcomes. 24. März 2021;19(1):106.
  302. Eckford RD, Gaisser A, Arndt V, Baumann M, Kludt E, Mehlis K, u. a. The COVID-19 Pandemic and Cancer Patients in Germany: Impact on Treatment, Follow-Up Care and Psychological Burden. Front Public Health. 2021;9:788598.
  303. Doege D, Thong MSY, Weißer L, Koch-Gallenkamp L, Jansen L, Bertram H, u. a. Health-Related Quality of Life in Very Long-Term Cancer Survivors 14-24 Years Post-Diagnosis Compared to Population Controls: A Population-Based Study. Cancers (Basel). 1. Juni 2021;13(11).
  304. Deppenwiese N, Delpy P, Lambarki M, Lablans M. ADT2FHIR - A Tool for Converting ADT/GEKID Oncology Data to HL7 FHIR Resources. Stud Health Technol Inform. 21. September 2021;283:104-10.
  305. Cardoso R, Guo F, Heisser T, Hackl M, Ihle P, De Schutter H, u. a. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. Juli 2021;22(7):1002-13.
  306. Bouvier AM, Jooste V, Sanchez-Perez MJ, Bento MJ, Rocha Rodrigues J, Marcos-Gragera R, u. a. Differences in the management and survival of metastatic colorectal cancer in Europe. A population-based study. Dig Liver Dis. Mai 2021;53(5):639-45.
  307. Teufel A, Gerken M, Fürst A, Ebert M, Hohenthanner I, Klinkhammer-Schalke M. Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer. Eur J Cancer. September 2020;137:148-60.
  308. Stangl S, Haas K, Eichner FA, Grau A, Selig U, Ludwig T, u. a. Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease-the "Breast cancer care for patients with metastatic disease" (BRE-4-MED) registry. Pilot Feasibility Stud. 2020;6:11.
  309. Spoerl S, Gerken M, Fischer R, Mamilos A, Spoerl S, Wolf S, u. a. Lymphatic and vascular invasion in oral squamous cell carcinoma: Implications for recurrence and survival in a population-based cohort study. Oral Oncol. Dezember 2020;111:105009.
  310. Spanier G, Böttcher J, Gerken M, Fischer R, Roth G, Lehn P, u. a. Prognostic value of perioperative red blood cell transfusion and anemia on survival and recurrence in oral squamous cell carcinoma. Oral Oncol. August 2020;107:104773.
  311. Sirri E, Kieschke J, Vohmann C, Katalinic A, Nennecke A, Ressing M, u. a. Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study. Int J Cancer. 15. September 2020;147(6):1548-58.
  312. Schmuck R, Gerken M, Teegen EM, Krebs I, Klinkhammer-Schalke M, Aigner F, u. a. Gender comparison of clinical, histopathological, therapeutic and outcome factors in 185,967 colon cancer patients. Langenbecks Arch Surg. Februar 2020;405(1):71-80.
  313. Schmidt ME, Hermann S, Arndt V, Steindorf K. Prevalence and severity of long-term physical, emotional, and cognitive fatigue across 15 different cancer entities. Cancer Med. November 2020;9(21):8053-61.
  314. Sant M, Meneghini E, Bastos J, Rossi PG, Guevara M, Innos K, u. a. Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study. Breast Cancer Res Treat. September 2020;183(2):439-50.
  315. Robold T, Neumeier J, Ried M, Neu R, Sziklavari Z, Grosser C, u. a. [Surgical Treatment of Lung Cancer: How Has the Introduction of the 8th Edition of the TNM Classification Affected Guideline-Based Therapy?]. Zentralbl Chir. Dezember 2020;145(6):589-96.
  316. Reinert C, Gerken M, Rathberger K, Krueger K, Klinkhammer-Schalke M, Lindberg-Scharf P, u. a. Single-institution cross-sectional study to evaluate need for information and need for referral to psychooncology care in association with depression in brain tumor patients and their family caregivers. BMC Psychol. 10. September 2020;8(1):96.
  317. Prantl L, Gerken M, Zeman F, Leitzmann M, Koller M, Klinkhammer-Schalke M, u. a. Incidence of Anaplastic Large Cell Lymphoma and Breast-Implant-Associated Lymphoma-An Analysis of a Certified Tumor Registry over 17 Years. J Clin Med. 25. April 2020;9(5).
  318. Papathemelis T, Scharl A, Anapolski M, C Inwald E, Ignatov A, Ortmann O, u. a. Value of indocyanine green pelvic lymph node mapping in the surgical approach of cervical cancer. Arch Gynecol Obstet. März 2020;301(3):787-92.
  319. Papathemelis T, Oppermann H, Grafl S, Gerken M, Pauer A, Scharl S, u. a. Long-term outcome of patients with intermediate- and high-risk endometrial cancer after pelvic and paraaortic lymph node dissection: a comparison of laparoscopic vs. open procedure. J Cancer Res Clin Oncol. April 2020;146(4):961-9.
  320. Minicozzi P, Vicentini M, Innos K, Castro C, Guevara M, Stracci F, u. a. Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study. Eur J Surg Oncol. Juni 2020;46(6):1151-9.
  321. Kowalski C, Albert US, Baumann W, Carl EG, Ernstmann N, Hermes-Moll K, u. a. [DNVF Memorandum Health Services Research in Oncology]. Gesundheitswesen. September 2020;82(8-09):e108-21.
  322. Klinkhammer-Schalke M, Steinger B, Koller M, Zeman F, Fürst A, Gumpp J, u. a. Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer. Eur J Cancer. Mai 2020;130:102-13.
  323. Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, Hübner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer. 1. August 2020;147(3):709-18.
  324. Jansen L, Holleczek B, Kraywinkel K, Weberpals J, Schröder CC, Eberle A, u. a. Divergent Patterns and Trends in Breast Cancer Incidence, Mortality and Survival Among Older Women in Germany and the United States. Cancers (Basel). 26. August 2020;12(9).
  325. Jansen L, Behrens G, Finke I, Maier W, Gerken M, Pritzkuleit R, u. a. Area-Based Socioeconomic Inequalities in Colorectal Cancer Survival in Germany: Investigation Based on Population-Based Clinical Cancer Registration. Front Oncol. 2020;10:857.
  326. Hübner J, Katalinic A, Waldmann A, Kraywinkel K. Long-term Incidence and Mortality Trends for Breast Cancer in Germany. Geburtshilfe Frauenheilkd. Juni 2020;80(6):611-8.
  327. Hellmund P, Schmitt J, Roessler M, Meier F, Schoffer O. Targeted and Checkpoint Inhibitor Therapy of Metastatic Malignant Melanoma in Germany, 2000-2016. Cancers (Basel). 20. August 2020;12(9).
  328. Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. Use of Complementary and Alternative Medicine among Young Patients with Breast Cancer. Breast Care (Basel). April 2020;15(2):163-70.
  329. Gebauer A, Barlag H, Wesselmann S, Biedenweg L, Weitmann K, Klinkhammer-Schalke M, u. a. [Evaluation of Quality Indicators of Evidence-Based Guidelines Using ADT/GEKID Base Dataset and its Organ-Specific Modules]. Gesundheitswesen. September 2020;82(8-09):710-5.
  330. Finke I, Behrens G, Schwettmann L, Gerken M, Pritzkuleit R, Holleczek B, u. a. Socioeconomic differences and lung cancer survival in Germany: Investigation based on population-based clinical cancer registration. Lung Cancer. April 2020;142:1-8.
  331. Doege D, Thong MSY, Koch-Gallenkamp L, Jansen L, Bertram H, Eberle A, u. a. Age-specific prevalence and determinants of depression in long-term breast cancer survivors compared to female population controls. Cancer Med. November 2020;9(22):8713-21.
  332. Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, u. a. Long-term relative survival from melanoma in Germany 1997-2013. Melanoma Res. August 2020;30(4):386-95.
  333. Bielska-Lasota M, Rossi S, KrzyŇľak M, Haelens A, Domenic A, De Angelis R, u. a. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Arch Gynecol Obstet. Februar 2020;301(2):591-602.
  334. Arndt V, Holleczek B, Kajüter H, Luttmann S, Nennecke A, Zeissig SR, u. a. Data from Population-based Cancer Registration for Secondary Data Analysis: Methodological Challenges and Perspectives. Gesundheitswesen. März 2020;82(S 01):S62-71.
  335. Wimmer T, Ortmann O, Gerken M, Klinkhammer-Schalke M, Koelbl O, Inwald EC. Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registry. Arch Gynecol Obstet. April 2019;299(4):1131-40.
  336. Völkel V, Draeger T, Schnitzbauer V, Gerken M, Benz S, Klinkhammer-Schalke M, u. a. Surgical treatment of rectal cancer patients aged 80 years and older-a German nationwide analysis comparing short- and long-term survival after laparoscopic and open tumor resection. Eur J Surg Oncol. September 2019;45(9):1607-12.
  337. Völkel V, Draeger T, Gerken M, Fürst A, Klinkhammer-Schalke M. [Long-Term Survival of Patients with Colon and Rectum Carcinomas: Is There a Difference Between Cancer Centers and Non-Certified Hospitals?]. Gesundheitswesen. Oktober 2019;81(10):801-7.
  338. Voelkel V, Draeger T, Groothuis-Oudshoorn CGM, de Munck L, Hueting T, Gerken M, u. a. Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany. J Cancer Res Clin Oncol. Juli 2019;145(7):1823-33.
  339. Sophia Rudolph CE, Katalinic A. [Baseline Incidence of HPV-Associated Invasive and in Situ Cancers in Germany Prior to Potential Vaccination Effects]. Gesundheitswesen. Dezember 2019;81(12):993-1000.
  340. Seliger C, Luber C, Gerken M, Schaertl J, Proescholdt M, Riemenschneider MJ, u. a. Use of metformin and survival of patients with high-grade glioma. Int J Cancer. 15. Januar 2019;144(2):273-80.
  341. Rudolph C, Petersen GS, Pritzkuleit R, Storm H, Katalinic A. The acceptance and applicability of a patient-reported experience measurement tool in oncological care: a descriptive feasibility study in northern Germany. BMC Health Serv Res. 1. November 2019;19(1):786.
  342. Papathemelis T, Knobloch S, Gerken M, Scharl A, Anapolski M, Ignatov A, u. a. Impact of nodal status and treatment strategy on overall survival in advanced stage cervical cancer. J Cancer Res Clin Oncol. Mai 2019;145(5):1369-76.
  343. Minicozzi P, Van Eycken L, Molinie F, Innos K, Guevara M, Marcos-Gragera R, u. a. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer. Int J Cancer. 1. Mai 2019;144(9):2118-27.
  344. Jobs A, Schwind J, Katalinic A, Babaev V, Tilz RR, Rausch S, u. a. Prognostic significance of atrial fibrillation in acute decompensated heart failure with reduced versus preserved ejection fraction. Clin Res Cardiol. Januar 2019;108(1):74-82.
  345. Hübner J, Lewin P, Pritzkuleit R, Eisemann N, Maier W, Katalinic A. Colorectal cancer screening by colonoscopy and trends in disease-specific mortality: a population-based ecological study of 358 German districts. Int J Colorectal Dis. April 2019;34(4):599-605.
  346. Hübner J, Hübner F, Terheyden P, Katalinic A. [Turning point in skin cancer mortality‚ÄĮ: An analysis of the trend in Germany from 1998 to 2017]. Hautarzt. Dezember 2019;70(12):989-92.
  347. Garbe C, Keim U, Eigentler TK, Amaral T, Katalinic A, Holleczek B, u. a. Time trends in incidence and mortality of cutaneous melanoma in Germany. J Eur Acad Dermatol Venereol. Juli 2019;33(7):1272-80.
  348. Draeger T, Völkel V, Schnitzbauer V, Gerken M, Benz S, Klinkhammer-Schalke M, u. a. Laparoscopic and open resection of rectal cancer-is age an effect modifier for short- and long-term survival? Int J Colorectal Dis. Mai 2019;34(5):821-8.
  349. Deck R, Babaev V, Katalinic A. [Reasons for the Non-Utilisation of an Oncological Rehabilitation. Results of a Written Survey with Patients of Oncological Healthcare Centers]. Rehabilitation (Stuttg). August 2019;58(4):243-52.
  350. Brunssen A, Jansen L, Eisemann N, Waldmann A, Weberpals J, Kraywinkel K, u. a. A population-based registry study on relative survival from melanoma in Germany stratified by tumor thickness for each histologic subtype. J Am Acad Dermatol. April 2019;80(4):938-46.
  351. Albert US, Schreer I. [S3 guideline breast cancer: update on early detection, and mammography screening]. Radiologe. Januar 2019;59(1):13-8.
  352. Wöckel A, Festl J, Stüber T, Brust K, Krockenberger M, Heuschmann PU, u. a. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer. Geburtshilfe Frauenheilkd. November 2018;78(11):1056-88.
  353. Wöckel A, Festl J, Stüber T, Brust K, Stangl S, Heuschmann PU, u. a. Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer. Geburtshilfe Frauenheilkd. Oktober 2018;78(10):927-48.
  354. Völkel V, Draeger T, Gerken M, Klinkhammer-Schalke M, Fürst A. Long-term oncologic outcomes after laparoscopic vs. open colon cancer resection: a high-quality population-based analysis in a Southern German district. Surg Endosc. Oktober 2018;32(10):4138-47.
  355. Seliger C, Schaertl J, Gerken M, Luber C, Proescholdt M, Riemenschneider MJ, u. a. Use of statins or NSAIDs and survival of patients with high-grade glioma. PLoS One. 2018;13(12):e0207858.
  356. Scharl S, Papathemelis T, Kronberger K, Gerken M, Scharl A, Kölbl O, u. a. Does post-operative radiochemotherapy improve survival in high-grade endometrial cancer patients? Results of a population-based cohort analysis of a cancer registry. Arch Gynecol Obstet. Mai 2018;297(5):1245-53.
  357. Sacchetto L, Zanetti R, Comber H, Bouchardy C, Brewster DH, Broganelli P, u. a. Trends in incidence of thick, thin and in situ melanoma in Europe. Eur J Cancer. März 2018;92:108-18.
  358. Reinert C, Rathberger K, Klinkhammer-Schalke M, Kölbl O, Proescholdt M, Riemenschneider MJ, u. a. Information needs and requirements in patients with brain tumours and their relatives. J Neurooncol. Juni 2018;138(2):407-15.
  359. Pulte D, Weberpals J, Schröder CC, Emrich K, Holleczek B, Katalinic A, u. a. Survival of patients with hepatobiliary tract and duodenal cancer sites in Germany and the United States in the early 21st century. Int J Cancer. 15. Juli 2018;143(2):324-32.
  360. Piso P, Stierstorfer K, Gerken M, Klinkhammer-Schalke M. Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer. Int J Colorectal Dis. November 2018;33(11):1559-67.
  361. Papathemelis T, Jablonski E, Scharl A, Hauzenberger T, Gerken M, Klinkhammer-Schalke M, u. a. Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM¬ģ Fluorescence Camera. Biomed Res Int. 2018;2018:6251468.
  362. Papathemelis T, Hassas D, Gerken M, Klinkhammer-Schalke M, Scharl A, Lux MP, u. a. Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis. J Cancer Res Clin Oncol. Oktober 2018;144(10):2019-27.
  363. Ott C, Gerken M, Hirsch D, Fest P, Fichtner-Feigl S, Munker S, u. a. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment. Digestion. 2018;98(3):143-52.
  364. Munker S, Gerken M, Fest P, Ott C, Schnoy E, Fichtner-Feigl S, u. a. Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects. BMC Cancer. 23. April 2018;18(1):455.
  365. Liebig-Hörl G, Puchner C, Gerken M, Klinkhammer-Schalke M, Fürst A. [Treatment strategy for early stage rectal cancer (T1 carcinoma)]. Chirurg. Mai 2018;89(5):358-64.
  366. Katalinic A. The Burden of Cancer in Germany. Dtsch Arztebl Int. 3. September 2018;115(35-36):569-70.
  367. Jobs A, Simon R, de Waha S, Rogacev K, Katalinic A, Babaev V, u. a. Pneumonia and inflammation in acute decompensated heart failure: a registry-based analysis of 1939 patients. Eur Heart J Acute Cardiovasc Care. Juni 2018;7(4):362-70.
  368. Jansen L, Buttmann-Schweiger N, Listl S, Ressing M, Holleczek B, Katalinic A, u. a. Differences in incidence and survival of oral cavity and pharyngeal cancers between Germany and the United States depend on the HPV-association of the cancer site. Oral Oncol. Januar 2018;76:8-15.
  369. Hübner J, Waldmann A, Eisemann N, Noftz M, Geller AC, Weinstock MA, u. a. Association between risk factors and detection of cutaneous melanoma in the setting of a population-based skin cancer screening. Eur J Cancer Prev. November 2018;27(6):563-9.
  370. Hübner J, Eisemann N, Brunßen A, Katalinic A. [Skin cancer screening in Germany: review after ten years]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Dezember 2018;61(12):1536-43.
  371. Hoebel J, Kroll LE, Fiebig J, Lampert T, Katalinic A, Barnes B, u. a. Socioeconomic Inequalities in Total and Site-Specific Cancer Incidence in Germany: A Population-Based Registry Study. Front Oncol. 2018;8:402.
  372. Hammersen F, Pursche T, Fischer D, Katalinic A, Waldmann A. [Signs of social inequality in information seeking and evaluation of information among young women with breast cancer - results of a cohort study]. Z Evid Fortbild Qual Gesundhwes. Dezember 2018;139:10-6.
  373. Eisemann N, Waldmann A, Holleczek B, Katalinic A. Observed and expected mortality in the German skin cancer screening pilot project SCREEN. J Med Screen. September 2018;25(3):166-8.
  374. Draeger T, Völkel V, Gerken M, Klinkhammer-Schalke M, Fürst A. Long-term oncologic outcomes after laparoscopic versus open rectal cancer resection: a high-quality population-based analysis in a Southern German district. Surg Endosc. Oktober 2018;32(10):4096-104.
  375. Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, u. a. Response: Methods for second primary cancers evaluation have to be standardized. Int J Cancer. 15. März 2018;142(6):1286-7.
  376. Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, NikŇ°ińá M, u. a. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37‚Äą513‚Äą025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 17. März 2018;391(10125):1023-75.
  377. Winter A, Sirri E, Jansen L, Wawroschek F, Kieschke J, Castro FA, u. a. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions? BJU Int. April 2017;119(4):550-9.
  378. Weberpals J, Pulte D, Jansen L, Luttmann S, Holleczek B, Nennecke A, u. a. Survival of patients with lymphoplasmacytic lymphoma and solitary plasmacytoma in Germany and the United States of America in the early 21(st) century. Haematologica. Juni 2017;102(6):e229-32.
  379. Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, u. a. International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol. Juni 2017;18(6):719-31.
  380. Schmick A, Juergensen M, Rohde V, Katalinic A, Waldmann A. Assessing health-related quality of life in urology - a survey of 4500 German urologists. BMC Urol. 19. Juni 2017;17(1):46.
  381. Pulte D, Weberpals J, Jansen L, Luttmann S, Holleczek B, Nennecke A, u. a. Survival for patients with rare haematologic malignancies: Changes in the early 21st century. Eur J Cancer. Oktober 2017;84:81-7.
  382. Pritzkuleit R, Eisemann N, Katalinic A. [The cartographic depiction of regional variation in morbidity‚ÄĮ: Data analysis options using the example of the small-scale cancer atlas for Schleswig-Holstein]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Dezember 2017;60(12):1319-27.
  383. Papathemelis T, Scharl S, Kronberger K, Gerken M, Scharl A, Pauer A, u. a. Survival benefit of pelvic and paraaortic lymphadenectomy in high-grade endometrial carcinoma: a retrospective population-based cohort analysis. J Cancer Res Clin Oncol. Dezember 2017;143(12):2555-62.
  384. Minicozzi P, Innos K, S√°nchez MJ, Trama A, Walsh PM, Marcos-Gragera R, u. a. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study. Eur J Cancer. Oktober 2017;84:335-53.
  385. Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, u. a. The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2). Gynecol Oncol. Februar 2017;144(2):405-13.
  386. Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, u. a. Erratum to "The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 405-413]. Gynecol Oncol. Dezember 2017;147(3):726.
  387. Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C. Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2). Gynecol Oncol. Februar 2017;144(2):396-404.
  388. Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C. Erratum to "Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 396-404]. Gynecol Oncol. Dezember 2017;147(3):725.
  389. Lindberg P, Netter P, Koller M, Steinger B, Klinkhammer-Schalke M. Breast cancer survivors` recollection of their quality of life: Identifying determinants of recall bias in a longitudinal population-based trial. PLoS One. 2017;12(2):e0171519.
  390. Leiter U, Keim U, Eigentler T, Katalinic A, Holleczek B, Martus P, u. a. Incidence, Mortality, and Trends of Nonmelanoma Skin Cancer in Germany. J Invest Dermatol. September 2017;137(9):1860-7.
  391. Klinkhammer-Schalke M, Steinger B, Koller M, Lindberg P. [Interventions to improve quality of life in oncological patients]. Z Evid Fortbild Qual Gesundhwes. Mai 2017;122:48-52.
  392. Jobs A, Brünjes K, Katalinic A, Babaev V, Desch S, Reppel M, u. a. Inferior vena cava diameter in acute decompensated heart failure as predictor of all-cause mortality. Heart Vessels. Juli 2017;32(7):856-64.
  393. Inwald EC, Ortmann O, Koller M, Zeman F, Hofstädter F, Evert M, u. a. Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Res Treat. Mai 2017;163(1):119-30.
  394. Hübner J, Waldmann A, Geller AC, Weinstock MA, Eisemann N, Noftz M, u. a. Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma. Br J Cancer. 17. Januar 2017;116(2):253-9.
  395. Holleczek B, Katalinic A. Toward a comprehensive cancer registration in Germany. Eur J Cancer Prev. September 2017;26 Joining forces for better cancer registration in Europe:S132-8.
  396. Hammersen F, Lewin P, Gebauer J, Kreitschmann-Andermahr I, Brabant G, Katalinic A, u. a. Sleep quality and health-related quality of life among long-term survivors of (non-) Hodgkin lymphoma in Germany. PLoS One. 2017;12(11):e0187673.
  397. Haj A, Doenitz C, Schebesch KM, Ehrensberger D, Hau P, Putnik K, u. a. Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center. Brain Sci. 25. Dezember 2017;8(1).
  398. Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, u. a. Increasing use of radical prostatectomy for locally advanced prostate cancer in the USA and Germany: a comparative population-based study. Prostate Cancer Prostatic Dis. März 2017;20(1):61-6.
  399. Gatta G, Peris-Bonet R, Visser O, Stiller C, Marcos-Gragera R, S√°nchez MJ, u. a. Geographical variability in survival of European children with central nervous system tumours. Eur J Cancer. September 2017;82:137-48.
  400. Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, u. a. Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5. Eur J Cancer. Mai 2017;77:140-52.
  401. Chen T, Brenner H, Fallah M, Jansen L, Castro FA, Geiss K, u. a. Risk of second primary cancers in women diagnosed with endometrial cancer in German and Swedish cancer registries. Int J Cancer. 1. Dezember 2017;141(11):2270-80.
  402. Brunssen A, Waldmann A, Eisemann N, Katalinic A. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review. J Am Acad Dermatol. Januar 2017;76(1):129-139.e10.
  403. Bonaventure A, Harewood R, Stiller CA, Gatta G, Clavel J, Stefan DC, u. a. Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89‚Äą828 children from 198 registries in 53 countries. Lancet Haematol. Mai 2017;4(5):e202-17.
  404. Sirri E, Castro FA, Kieschke J, Jansen L, Emrich K, Gondos A, u. a. Recent Trends in Survival of Patients With Pancreatic Cancer in Germany and the United States. Pancreas. Juli 2016;45(6):908-14.
  405. Pulte D, Jansen L, Castro FA, Krilaviciute A, Katalinic A, Barnes B, u. a. Survival in patients with acute myeloblastic leukemia in Germany and the United States: Major differences in survival in young adults. Int J Cancer. 15. September 2016;139(6):1289-96.
  406. Pulte D, Castro FA, Jansen L, Luttmann S, Holleczek B, Nennecke A, u. a. Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century. J Hematol Oncol. 22. März 2016;9:28.
  407. Peller M, Katalinic A, Wollenberg B, Teudt IU, Meyer JE. Epidemiology of laryngeal carcinoma in Germany, 1998-2011. Eur Arch Otorhinolaryngol. Juni 2016;273(6):1481-7.
  408. Merz M, Jansen L, Castro FA, Hillengass J, Salwender H, Weisel K, u. a. Survival of elderly patients with multiple myeloma-Effect of upfront autologous stem cell transplantation. Eur J Cancer. Juli 2016;62:1-8.
  409. Liu L, O'Donnell P, Sullivan R, Katalinic A, Moser L, de Boer A, u. a. Cancer in Europe: Death sentence or life sentence? Eur J Cancer. September 2016;65:150-5.
  410. Katalinic A. [Improved prognosis for symptom-free older women with mammography-detected breast cancer?]. Strahlenther Onkol. Februar 2016;192(2):130-2.
  411. Heywang-Köbrunner SH, Schreer I, Hacker A, Noftz MR, Katalinic A. Conclusions for mammography screening after 25-year follow-up of the Canadian National Breast Cancer Screening Study (CNBSS). Eur Radiol. Februar 2016;26(2):342-50.
  412. Eisemann N, Schnoor M, Katalinic A. Prediction of chronic lymphocytic leukaemia incidence in Germany and of patients ineligible for standard chemotherapy. Hematol Oncol. Juni 2016;34(2):93-101.
  413. Eisemann N, Jansen L, Castro FA, Chen T, Eberle A, Nennecke A, u. a. Survival with nonmelanoma skin cancer in Germany. Br J Dermatol. April 2016;174(4):778-85.
  414. Chen T, Fallah M, Brenner H, Jansen L, Mai EK, Castro FA, u. a. Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries. Sci Rep. 24. Februar 2016;6:22084.
  415. Brenner H, Schrotz-King P, Holleczek B, Katalinic A, Hoffmeister M. Declining Bowel Cancer Incidence and Mortality in Germany. Dtsch Arztebl Int. 19. Februar 2016;113(7):101-6.
  416. Brenner H, Castro FA, Eberle A, Emrich K, Holleczek B, Katalinic A, u. a. Death certificate only proportions should be age adjusted in studies comparing cancer survival across populations and over time. Eur J Cancer. Januar 2016;52:102-8.
  417. Adzersen KH, Friedrich S, Becker N. Are epidemiological data on lymphoma incidence comparable? Results from an application of the coding recommendations of WHO, InterLymph, ENCR and SEER to a cancer registry dataset. J Cancer Res Clin Oncol. Januar 2016;142(1):167-75.
  418. Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P. Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study. Eur J Cancer. Oktober 2015;51(15):2231-41.
  419. Trama A, Foschi R, Larra√Īaga N, Sant M, Fuentes-Raspall R, Serraino D, u. a. Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study. Eur J Cancer. Oktober 2015;51(15):2206-16.
  420. Storm HH, Engholm G, Pritzkuleit R, Kejs AMT, Katalinic A, Dunst J, u. a. Less pitfalls and variation in population based cancer survival comparisons within the European Union: Lessons from colorectal cancer patients in neighbouring regions in Denmark and Germany - The Fehmarn Belt project. Eur J Cancer. Juni 2015;51(9):1188-98.
  421. Sant M, Chirlaque Lopez MD, Agresti R, S√°nchez Pérez MJ, Holleczek B, Bielska-Lasota M, u. a. Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study. Eur J Cancer. Oktober 2015;51(15):2191-205.
  422. Rudolph C, Schnoor M, Eisemann N, Katalinic A. Incidence trends of nonmelanoma skin cancer in Germany from 1998 to 2010. J Dtsch Dermatol Ges. August 2015;13(8):788-97.
  423. Rossi S, Baili P, Capocaccia R, Caldora M, Carrani E, Minicozzi P, u. a. The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods. Eur J Cancer. Oktober 2015;51(15):2104-19.
  424. Pulte D, Jansen L, Castro FA, Emrich K, Katalinic A, Holleczek B, u. a. Trends in survival of multiple myeloma patients in Germany and the United States in the first decade of the 21st century. Br J Haematol. Oktober 2015;171(2):189-96.
  425. Peters E, Anzeneder T, Jackisch C, Dimpfl T, Kunz G, Katalinic A, u. a. The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-up. Dtsch Arztebl Int. 31. August 2015;112(35-36):577-84.
  426. Mounier M, Bossard N, Remontet L, Belot A, Minicozzi P, De Angelis R, u. a. Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5). Lancet Haematol. November 2015;2(11):e481-491.
  427. Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Allory Y, u. a. Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5. Eur J Cancer. Oktober 2015;51(15):2217-30.
  428. Lindberg P, Koller M, Steinger B, Lorenz W, Wyatt JC, Inwald EC, u. a. Breast cancer survivors' recollection of their illness and therapy seven years after enrolment into a randomised controlled clinical trial. BMC Cancer. 29. Juli 2015;15:554.
  429. Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio D, u. a. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5. Eur J Cancer. Oktober 2015;51(15):2169-78.
  430. Klinkhammer-Schalke M, Gerken M, Barlag H, Tillack A. [Quality management in oncology supported by clinical cancer registries]. Z Evid Fortbild Qual Gesundhwes. 2015;109(6):452-8.
  431. Katalinic A, Eisemann N, Waldmann A. Skin Cancer Screening in Germany. Documenting Melanoma Incidence and Mortality From 2008 to 2013. Dtsch Arztebl Int. 18. September 2015;112(38):629-34.
  432. Katalinic A. [Cancer screening-- sense or nonsense?]. Oncol Res Treat. 2015;38 Suppl 3:12.
  433. Katalinic A. [Commentary on the article "Skin cancer screening in Germany" by Blum et al]. Hautarzt. Juli 2015;66(7):540-1.
  434. Jansen L, Castro FA, Gondos A, Krilaviciute A, Barnes B, Eberle A, u. a. Recent cancer survival in Germany: an analysis of common and less common cancers. Int J Cancer. 1. Juni 2015;136(11):2649-58.
  435. Hübner J, Noftz MR, Schnoor M, Katalinic A. [Erratum to: Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling]. Internist (Berl). Juni 2015;56(6):716.
  436. Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci S, u. a. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 - Results from the EUROCARE-5 study. Eur J Cancer. Oktober 2015;51(15):2158-68.
  437. Hermann S, Friedrich S, Haug U, Rohrmann S, Becker N, Kaaks R. Association between socioeconomic and demographic characteristics and utilization of colonoscopy in the EPIC-Heidelberg cohort. Eur J Cancer Prev. März 2015;24(2):81-8.
  438. Haug U, Rösch T, Hoffmeister M, Katalinic A, Brenner H, Becker N. [Implementing an Organised Colorectal Cancer Screening Programme in Germany: Opportunities and Challenges]. Gesundheitswesen. November 2015;77(11):869-74.
  439. Hager B, Kraywinkel K, Keck B, Katalinic A, Meyer M, Zeissig SR, u. a. Integrated prostate cancer centers might cause an overutilization of radiotherapy for low-risk prostate cancer: A comparison of treatment trends in the United States and Germany from 2004 to 2011. Radiother Oncol. April 2015;115(1):90-5.
  440. Gebauer J, Fick EM, Waldmann A, Langer T, Kreitschmann-Andermahr I, Lehnert H, u. a. Self-reported endocrine late effects in adults treated for brain tumours, Hodgkin and non-Hodgkin lymphoma: a registry based study in Northern Germany. Eur J Endocrinol. August 2015;173(2):139-48.
  441. Gatta G, Botta L, S√°nchez MJ, Anderson LA, Pierannunzio D, Licitra L. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. Eur J Cancer. Oktober 2015;51(15):2130-43.
  442. Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, u. a. Survival patterns in lung and pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study. Eur J Cancer. Oktober 2015;51(15):2242-53.
  443. Fick EM, Katalinic A, Waldmann A. The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany. Cancer Res Treat. Oktober 2015;47(4):747-56.
  444. Eisemann N, Waldmann A, Garbe C, Katalinic A. Development of a microsimulation of melanoma mortality for evaluating the effectiveness of population-based skin cancer screening. Med Decis Making. Februar 2015;35(2):243-54.
  445. Eisemann N, Nolte S, Schnoor M, Katalinic A, Rohde V, Waldmann A. The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study. BMC Urol. 10. April 2015;15:28.
  446. Eberle A, Jansen L, Castro F, Krilaviciute A, Luttmann S, Emrich K, u. a. Lung cancer survival in Germany: A population-based analysis of 132,612 lung cancer patients. Lung Cancer. Dezember 2015;90(3):528-33.
  447. De Angelis R, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, u. a. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study. Eur J Cancer. Oktober 2015;51(15):2254-68.
  448. Crocetti E, Mallone S, Robsahm TE, Gavin A, Agius D, Ardanaz E, u. a. Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study. Eur J Cancer. Oktober 2015;51(15):2179-90.
  449. Chen T, Fallah M, Jansen L, Castro FA, Krilavicuite A, Katalinic A, u. a. Distribution and risk of the second discordant primary cancers combined after a specific first primary cancer in German and Swedish cancer registries. Cancer Lett. 1. Dezember 2015;369(1):152-66.
  450. Castro FA, Jansen L, Krilaviciute A, Katalinic A, Pulte D, Sirri E, u. a. Survival of patients with gastric lymphoma in Germany and in the United States. J Gastroenterol Hepatol. Oktober 2015;30(10):1485-91.
  451. Boniol M, Autier P, Gandini S. Melanoma mortality following skin cancer screening in Germany. BMJ Open. 15. September 2015;5(9):e008158.
  452. Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, u. a. Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study. Eur J Cancer. Oktober 2015;51(15):2120-9.
  453. Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, u. a. Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5. Eur J Cancer. Oktober 2015;51(15):2144-57.
  454. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, u. a. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 14. März 2015;385(9972):977-1010.
  455. Zanetti R, Sacchetto L, Calvia M, Bordoni A, Hakulinen T, Znaor A, u. a. Economic evaluation of cancer registration in Europe. J Registry Manag. Spring 2014;41(1):31-7.
  456. Waldmann A, Anzeneder T, Katalinic A. Patients and Methods of the PATH Biobank - A Resource for Breast Cancer Research. Geburtshilfe Frauenheilkd. April 2014;74(4):361-9.
  457. Schönfeld I, Kraywinkel K. [Epidemiological cancer data online: an overview of information service in Germany and Europe]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Januar 2014;57(1):22-6.
  458. Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, u. a. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol. August 2014;15(9):931-42.
  459. Pulte D, Jansen L, Gondos A, Katalinic A, Barnes B, Ressing M, u. a. Survival of adults with acute lymphoblastic leukemia in Germany and the United States. PLoS One. 2014;9(1):e85554.
  460. Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, u. a. Improved population level survival in younger Hodgkin lymphoma patients in Germany in the early 21st century. Br J Haematol. März 2014;164(6):851-7.
  461. Nennecke A, Geiss K, Hentschel S, Vettorazzi E, Jansen L, Eberle A, u. a. Survival of cancer patients in urban and rural areas of Germany--a comparison. Cancer Epidemiol. Juni 2014;38(3):259-65.
  462. Kapsimalakou S, Waldmann A, Katalinic A, Grande-Nagel I, Fischer D, Barkhausen J, u. a. Follow-up of probably benign lesions in non-screening breast diagnostics. Arch Gynecol Obstet. September 2014;290(3):543-51.
  463. Jansen L, Eberle A, Emrich K, Gondos A, Holleczek B, Kajüter H, u. a. Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer. 15. Juni 2014;134(12):2951-60.
  464. Hübner J, Noftz MR, Schnoor M, Katalinic A. [Screening for colorectal, skin, breast and prostate cancer. Essential knowledge for counseling]. Internist (Berl). Oktober 2014;55(10):1171-81.
  465. Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, u. a. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study. Lancet Oncol. Januar 2014;15(1):35-47.
  466. Eisemann N, Waldmann A, Rohde V, Katalinic A. Quality of life in partners of patients with localised prostate cancer. Qual Life Res. Juni 2014;23(5):1557-68.
  467. Eisemann N, Waldmann A, Geller AC, Weinstock MA, Volkmer B, Greinert R, u. a. Non-melanoma skin cancer incidence and impact of skin cancer screening on incidence. J Invest Dermatol. Januar 2014;134(1):43-50.
  468. Eisemann N, Waldmann A, Katalinic A. [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Januar 2014;57(1):77-83.
  469. De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, u. a. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol. Januar 2014;15(1):23-34.
  470. Breitbart EW, Choudhury K, Anders MP, Volkmer B, Greinert R, Katalinic A, u. a. Benefits and risks of skin cancer screening. Oncol Res Treat. 2014;37 Suppl 3:38-47.
  471. Waldmann A, Schubert D, Katalinic A. Normative data of the EORTC QLQ-C30 for the German population: a population-based survey. PLoS One. 2013;8(9):e74149.
  472. Waldmann A, Eisemann N, Katalinic A. Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends. Geburtshilfe Frauenheilkd. Februar 2013;73(2):123-9.
  473. Stang A, Jansen L, Trabert B, Rusner C, Eberle A, Katalinic A, u. a. Survival after a diagnosis of testicular germ cell cancers in Germany and the United States, 2002-2006: a high resolution study by histology and age. Cancer Epidemiol. August 2013;37(4):492-7.
  474. Schnoor M, Hallof A, Hergert-Lüder D, Katalinic A, Waldmann A. [Reasons for non-participation in mammography screening--a survey in Schleswig-Holstein, Germany]. Dtsch Med Wochenschr. November 2013;138(45):2289-94.
  475. Rusner C, Trabert B, Katalinic A, Kieschke J, Emrich K, Stang A. Incidence patterns and trends of malignant gonadal and extragonadal germ cell tumors in Germany, 1998-2008. Cancer Epidemiol. August 2013;37(4):370-3.
  476. Pulte D, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, u. a. Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century. Leuk Lymphoma. Mai 2013;54(5):979-85.
  477. Pulte D, Barnes B, Jansen L, Eisemann N, Emrich K, Gondos A, u. a. Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century. J Hematol Oncol. 16. September 2013;6(1):70.
  478. Nennecke A, Barnes B, Brenner H, Eberle A, Emrich K, Eisemann N, u. a. [Data quality or differences in oncological care? - standards of reporting for cancer survival analyses based on registry data]. Gesundheitswesen. Februar 2013;75(2):94-8.
  479. Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, u. a. Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in Germany. PLoS One. 2013;8(7):e68077.
  480. Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, u. a. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up. Eur J Cancer Prev. Mai 2013;22(3):210-4.
  481. Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, u. a. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects. Cancer Med. Oktober 2013;2(5):718-24.
  482. Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczek B, u. a. Survival of patients with oral cavity cancer in Germany. PLoS One. 2013;8(1):e53415.
  483. Inwald EC, Klinkhammer-Schalke M, Hofstädter F, Zeman F, Koller M, Gerstenhauer M, u. a. Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry. Breast Cancer Res Treat. Juni 2013;139(2):539-52.
  484. Greiner F, Nolte S, Waldmann A, Katalinic A, Breitbart EW. [Collection and processing of personal data to evaluate cancer screening programmes - results of a survey of the German population in light of the bill 'early detection of cancer and cancer registries']. Gesundheitswesen. November 2013;75(11):751-3.
  485. Gondos A, Hiripi E, Holleczek B, Luttmann S, Eberle A, Brenner H. Survival among adolescents and young adults with cancer in Germany and the United States: an international comparison. Int J Cancer. November 2013;133(9):2207-15.
  486. Fick EM, Anzeneder T, Katalinic A, Waldmann A. Bisphosphonates and their Role in Therapy for Breast Cancer - Results from the PATH Biobank. Geburtshilfe Frauenheilkd. Mai 2013;73(5):412-21.
  487. Eisemann N, Waldmann A, Katalinic A. Epidemiology of Breast Cancer - Current Figures and Trends. Geburtshilfe Frauenheilkd. Februar 2013;73(2):130-5.
  488. Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, u. a. Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stage. Eur J Cancer Prev. Januar 2013;22(1):59-67.
  489. Waldmann A, Nolte S, Geller AC, Katalinic A, Weinstock MA, Volkmer B, u. a. Frequency of excisions and yields of malignant skin tumors in a population-based screening intervention of 360,288 whole-body examinations. Arch Dermatol. August 2012;148(8):903-10.
  490. Waldmann A, Kapsimalakou S, Katalinic A, Grande-Nagel I, Stoeckelhuber BM, Fischer D, u. a. Benefits of the quality assured double and arbitration reading of mammograms in the early diagnosis of breast cancer in symptomatic women. Eur Radiol. Mai 2012;22(5):1014-22.
  491. Waldmann A, Nolte S, Weinstock MA, Breitbart EW, Eisemann N, Geller AC, u. a. Skin cancer screening participation and impact on melanoma incidence in Germany--an observational study on incidence trends in regions with and without population-based screening. Br J Cancer. 28. Februar 2012;106(5):970-4.
  492. Waldmann A, Adrich S, Eisemann N, Fauteck H, Grande-Nagel I, Schaefer FKW, u. a. [Structure and process quality of quality-assured mamma diagnostics in Schleswig-Holstein]. Rofo. Februar 2012;184(2):113-21.
  493. Schnoor M, Waldmann A, Eberle A, Holleczek B, Katalinic A. Colorectal cancer incidence in Germany: stage-shift 6 years after implementation of a colonoscopy screening program. Cancer Epidemiol. Oktober 2012;36(5):417-20.
  494. Rusner C, Bandemer-Greulich U, Engel J, Stegmaier C, Zawinell A, Holleczek B, u. a. Population-based hormone receptor-specific incidence trends of breast cancer in Germany. Maturitas. Oktober 2012;73(2):152-7.
  495. Perl M, Waldmann A, Pritzkuleit R, Katalinic A. [Temporal changes in quality of life after prostate carcinoma]. Urologe A. Mai 2012;51(5):706-12.
  496. Majek O, Gondos A, Jansen L, Emrich K, Holleczek B, Katalinic A, u. a. Survival from colorectal cancer in Germany in the early 21st century. Br J Cancer. 22. Mai 2012;106(11):1875-80.
  497. Katalinic A, Waldmann A, Weinstock MA, Geller AC, Eisemann N, Greinert R, u. a. Does skin cancer screening save lives?: an observational study comparing trends in melanoma mortality in regions with and without screening. Cancer. 1. November 2012;118(21):5395-402.
  498. Jansen L, Gondos A, Eberle A, Emrich K, Holleczek B, Katalinic A, u. a. Cancer survival in Eastern and Western Germany after the fall of the iron curtain. Eur J Epidemiol. September 2012;27(9):689-93.
  499. Hiripi E, Jansen L, Gondos A, Emrich K, Holleczek B, Katalinic A, u. a. Survival of stomach and esophagus cancer patients in Germany in the early 21st century. Acta Oncol. September 2012;51(7):906-14.
  500. Hiripi E, Gondos A, Emrich K, Holleczek B, Katalinic A, Luttmann S, u. a. Survival from common and rare cancers in Germany in the early 21st century. Ann Oncol. Februar 2012;23(2):472-9.
  501. Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Trends in incidence, tumour sites and tumour stages of oral and pharyngeal cancer in Northern Germany. J Cancer Res Clin Oncol. März 2012;138(3):431-7.
  502. Hertrampf K, Wiltfang J, Katalinic A, Timm O, Wenz HJ. Recent trends in incidence and mortality of oral and pharyngeal cancer in Schleswig-Holstein in Northern Germany. Community Dent Health. Dezember 2012;29(4):268-73.
  503. Eisemann N, Jansen L, Holleczek B, Waldmann A, Luttmann S, Emrich K, u. a. Up-to-date results on survival of patients with melanoma in Germany. Br J Dermatol. September 2012;167(3):606-12.
  504. Chen T, Jansen L, Gondos A, Ressing M, Holleczek B, Katalinic A, u. a. Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. BMC Cancer. 30. März 2012;12:128.
  505. Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Luttmann S, u. a. Survival of cervical cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage. Acta Oncol. September 2012;51(7):915-21.
  506. Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, u. a. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. Februar 2012;66(2):201-11.
  507. Waldmann A, Nolte S, Pritzkuleit R, Breitbart EW, Katalinic A. Different aspects of self-reported quality of life in 450 german melanoma survivors. Cancers (Basel). 11. Mai 2011;3(2):2316-32.
  508. Obi N, Waldmann A, Schäfer F, Schreer I, Katalinic A. Impact of the Quality assured Mamma Diagnostic (QuaMaDi) programme on survival of breast cancer patients. Cancer Epidemiol. Juni 2011;35(3):286-92.
  509. Obi N, Waldmann A, Babaev V, Katalinic A. [Record linkage of a large clinical practice patient cohort with the Cancer Registry Schleswig-Holstein]. Gesundheitswesen. Juli 2011;73(7):452-8.
  510. Hakulinen T, Arbyn M, Brewster DH, Coebergh JW, Coleman MP, Crocetti E, u. a. Harmonization may be counterproductive--at least for parts of Europe where public health research operates effectively. Eur J Public Health. Dezember 2011;21(6):686-7.
  511. Eisemann N, Waldmann A, Katalinic A. Imputation of missing values of tumour stage in population-based cancer registration. BMC Med Res Methodol. 19. September 2011;11:129.
  512. Dittmer C, Katalinic A, Mundhenke C, Thill M, Fischer D. Epidemiology of vulvar and vaginal cancer in Germany. Arch Gynecol Obstet. Juli 2011;284(1):169-74.
  513. Brenner H, Altenhofen L, Katalinic A, Lansdorp-Vogelaar I, Hoffmeister M. Sojourn time of preclinical colorectal cancer by sex and age: estimates from the German national screening colonoscopy database. Am J Epidemiol. 15. November 2011;174(10):1140-6.
  514. Waldmann A, Eberle A, Hentschel S, Holleczek B, Katalinic A. [Population-based incidence rates of colorectal neoplasms (2000 - 2006) - has systematic colonoscopy screening an impact on incidence? A combined analysis of cancer registry data of the Federal States of Bremen, Hamburg, Saarland and Schleswig-Holstein]. Z Gastroenterol. Dezember 2010;48(12):1358-66.
  515. Waldmann A, Dreckschmidt J, Pritzkuleit R, Katalinic A. [Test-retest reliability of the OVIS Questionnaire--an instrument to evaluate oncological care from a patient's point of view]. Gesundheitswesen. Oktober 2010;72(10):707-13.
  516. Stang A, Katalinic A, Dieckmann KP, Pritzkuleit R, Stabenow R. A novel approach to estimate the German-wide incidence of testicular cancer. Cancer Epidemiol. Februar 2010;34(1):13-9.
  517. Schaefer FKW, Waldmann A, Katalinic A, Wefelnberg C, Heller M, Jonat W, u. a. Influence of additional breast ultrasound on cancer detection in a cohort study for quality assurance in breast diagnosis--analysis of 102,577 diagnostic procedures. Eur Radiol. Mai 2010;20(5):1085-92.
  518. Pritzkuleit R, Beske F, Katalinic A. [Demographic change and cancer]. Onkologie. 2010;33 Suppl 7:19-24.
  519. Pritzkuleit R, Beske F, Katalinic A. [Disease numbers in pneumology - a projection to 2060]. Pneumologie. September 2010;64(9):535-40.
  520. Katalinic A, Peters E, Beske F, Pritzkuleit R. Projection of Morbidity 2030 and 2050: Impact for the National Health System and Blood Supply. Transfus Med Hemother. Juni 2010;37(3):155-9.
  521. Hug K, Grize L, Seidler A, Kaatsch P, Schüz J. Parental occupational exposure to extremely low frequency magnetic fields and childhood cancer: a German case-control study. Am J Epidemiol. 1. Januar 2010;171(1):27-35.
  522. Haberland J, Bertz J, Wolf U, Ziese T, Kurth BM. German cancer statistics 2004. BMC Cancer. 22. Februar 2010;10:52.
  523. Geller AC, Greinert R, Sinclair C, Weinstock MA, Aitken J, Boniol M, u. a. A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol. Juni 2010;34(3):355-8.
  524. Waldmann A, Rohde V, Bremner K, Krahn M, Kuechler T, Katalinic A. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P). BMC Cancer. 23. August 2009;9:295.
  525. Waldmann A, Raspe H, Katalinic A. [Colon cancer risk in persons at familial or hereditary risk aged < 55 years]. Z Gastroenterol. Oktober 2009;47(10):1052-8.
  526. Stanulla M, Schaeffeler E, Möricke A, Coulthard SA, Cario G, Schrauder A, u. a. Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols. Blood. 13. August 2009;114(7):1314-8.
  527. Spix C, Blettner M. Re: BAKER P.J. & HOEL D.G. (2007) European Journal of Cancer Care16, 355-363. Meta-analysis of standardized incidence and mortality rates of childhood leukaemia in proximity to nuclear facilities. Eur J Cancer Care (Engl). Juli 2009;18(4):429-30.
  528. Spix C, Schulze-Rath R, Kaatsch P, Blettner M. Case-control study on risk factors for leukaemia and brain tumours in children under 5 years in Germany. Klin Padiatr. Dezember 2009;221(6):362-8.
  529. Spix C, Mergenthaler A, Kaatsch P. [Data exchange between the German Childhood Cancer Registry and the Epidemiological Cancer State Registries]. Klin Padiatr. Dezember 2009;221(6):398-9.
  530. Schafmayer C, Buch S, Völzke H, von Schönfels W, Egberts JH, Schniewind B, u. a. Investigation of the colorectal cancer susceptibility region on chromosome 8q24.21 in a large German case-control sample. Int J Cancer. 1. Januar 2009;124(1):75-80.
  531. Rohde V, Weidner W, Katalinic A. Decrease in prostate cancer incidence and mortality in Germany - effects of opportunistic PSA screening or more? Urol Int. 2009;83(2):134-40.
  532. Ludwig AK, Katalinic A, Entenmann A, Thyen U, Sutcliffe AG, Diedrich K, u. a. Can we sense ART? The blinded examiner is not blind-a problem with follow-up studies on children born after assisted reproduction. Fertil Steril. September 2009;92(3):950-2.
  533. Loerbroks A, Apfelbacher CJ, Thayer JF, Debling D, Stürmer T. Neuroticism, extraversion, stressful life events and asthma: a cohort study of middle-aged adults. Allergy. Oktober 2009;64(10):1444-50.
  534. Katalinic A, Pritzkuleit R, Waldmann A. Recent Trends in Breast Cancer Incidence and Mortality in Germany. Breast Care (Basel). 2009;4(2):75-80.
  535. Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A. Trends in hormone therapy and breast cancer incidence - results from the German Network of Cancer Registries. Pathobiology. 2009;76(2):90-7.
  536. Katalinic A, Raspe H, Waldmann A. [Positive family history of colorectal cancer--use of a questionnaire]. Z Gastroenterol. November 2009;47(11):1125-31.
  537. Kaatsch P, Reinisch I, Spix C, Berthold F, Janka-Schaub G, Mergenthaler A, u. a. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany. Cancer Causes Control. August 2009;20(6):965-80.
  538. Kaatsch P, Debling D, Blettner M, Spix C. Second malignant neoplasms after childhood cancer in Germany--results from the long-term follow-up of the German Childhood Cancer Registry. Strahlenther Onkol. August 2009;185 Suppl 2:8-10.
  539. Hammer GP, Seidenbusch MC, Schneider K, Regulla DF, Zeeb H, Spix C, u. a. A cohort study of childhood cancer incidence after postnatal diagnostic X-ray exposure. Radiat Res. April 2009;171(4):504-12.
  540. Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, u. a. Survival of European children and young adults with cancer diagnosed 1995-2002. Eur J Cancer. April 2009;45(6):992-1005.
  541. Weihkopf T, Blettner M, Dantonello T, Jung I, Klingebiel T, Koscielniak E, u. a. Incidence and time trends of soft tissue sarcomas in German children 1985-2004 - a report from the population-based German Childhood Cancer Registry. Eur J Cancer. Februar 2008;44(3):432-40.
  542. Waldmann A, Pritzkuleit R, Raspe H, Katalinic A. Guideline-compatible treatment of breast cancer patients: the status quo in schleswig-holstein. Dtsch Arztebl Int. Mai 2008;105(18):337-43.
  543. Spix C, Spallek J, Kaatsch P, Razum O, Zeeb H. Cancer survival among children of Turkish descent in Germany 1980-2005: a registry-based analysis. BMC Cancer. 28. November 2008;8:355.
  544. Spix C, Schmiedel S, Kaatsch P, Schulze-Rath R, Blettner M. Case-control study on childhood cancer in the vicinity of nuclear power plants in Germany 1980-2003. Eur J Cancer. Januar 2008;44(2):275-84.
  545. Spix C, Eletr D, Blettner M, Kaatsch P. Temporal trends in the incidence rate of childhood cancer in Germany 1987-2004. Int J Cancer. 15. April 2008;122(8):1859-67.
  546. Spallek J, Spix C, Zeeb H, Kaatsch P, Razum O. Cancer patterns among children of Turkish descent in Germany: a study at the German Childhood Cancer Registry. BMC Public Health. 7. Mai 2008;8:152.
  547. Reinhard H, Reinert J, Beier R, Furtwängler R, Alkasser M, Rutkowski S, u. a. Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in Germany. Oncol Rep. März 2008;19(3):819-23.
  548. Pritzkuleit R, Waldmann A, Raspe H, Katalinic A. The population-based oncological health care study OVIS - recruitment of the patients and analysis of the non-participants. BMC Cancer. 27. Oktober 2008;8:311.
  549. Pommerening K, Debling D, Kaatsch P, Blettner M. [Registries for rare diseases. Compliance and data protection]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Mai 2008;51(5):491-9.
  550. Merzenich H, Schmiedel S, Bennack S, Brüggemeyer H, Philipp J, Blettner M, u. a. Childhood leukemia in relation to radio frequency electromagnetic fields in the vicinity of TV and radio broadcast transmitters. Am J Epidemiol. 15. November 2008;168(10):1169-78.
  551. Laengler A, Spix C, Seifert G, Gottschling S, Graf N, Kaatsch P. Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany. Eur J Cancer. Oktober 2008;44(15):2233-40.
  552. Katalinic A, Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat. Februar 2008;107(3):427-30.
  553. Kaatsch P, Spix C, Schulze-Rath R, Schmiedel S, Blettner M. Leukaemia in young children living in the vicinity of German nuclear power plants. Int J Cancer. 15. Februar 2008;122(4):721-6.
  554. Kaatsch P, Spix C, Jung I, Blettner M. Childhood leukemia in the vicinity of nuclear power plants in Germany. Dtsch Arztebl Int. Oktober 2008;105(42):725-32.
  555. Kaatsch P, Mergenthaler A. Incidence, time trends and regional variation of childhood leukaemia in Germany and Europe. Radiat Prot Dosimetry. 2008;132(2):107-13.
  556. Hüppe D, Hartmann H, Felten G, Kemen M, Tannapfel A, Gillessen A, u. a. [Effectiveness of screening colonoscopy in a community-based study]. Z Gastroenterol. Februar 2008;46(2):193-200.
  557. Heywang-Köbrunner SH, Schreer I, Heindel W, Katalinic A. Imaging studies for the early detection of breast cancer. Dtsch Arztebl Int. August 2008;105(31-32):541-7.
  558. Debling D, Spix C, Blettner M, Michaelis J, Kaatsch P. The cohort of long-term survivors at the German childhood cancer registry. Klin Padiatr. Dezember 2008;220(6):371-7.
  559. Borgmann A, Zinn C, Hartmann R, Herold R, Kaatsch P, Escherich G, u. a. Secondary malignant neoplasms after intensive treatment of relapsed acute lymphoblastic leukaemia in childhood. Eur J Cancer. Januar 2008;44(2):257-68.
  560. Beelte AK, Pritzkuleit R, Katalinic A. [Lung cancer incidence and mortality: current trends and projections based on data from Schleswig-Holstein]. Dtsch Med Wochenschr. Juli 2008;133(28-29):1487-92.
  561. Waldmann A, Pritzkuleit R, Raspe H, Katalinic A. The OVIS study: health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein. Qual Life Res. Juni 2007;16(5):767-76.
  562. Waldmann A, Lautz E, Hampe J, Schreiber S, Schafmayer C, Katalinic A. [Utilization of inpatient rehabilitation of younger patients with colorectal neoplasms--results of the project "Popgen-colorectal cancer"]. Rehabilitation (Stuttg). Dezember 2007;46(6):349-55.
  563. Waldmann A, Lautz E, Hampe J, Schreiber S, Schafmayer C, Raspe H, u. a. [Description of the medical care of younger patients (<65 years) with colorectal cancer in Schleswig-Holstein--are diagnostics and therapy compliant with the actual S3-guidelines?]. Gesundheitswesen. April 2007;69(4):216-23.
  564. Svendsen AL, Weihkopf T, Kaatsch P, Schüz J. Exposure to magnetic fields and survival after diagnosis of childhood leukemia: a German cohort study. Cancer Epidemiol Biomarkers Prev. Juni 2007;16(6):1167-71.
  565. Schüz J, Weihkopf T, Kaatsch P. Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr. Mai 2007;166(5):433-41.
  566. Schüz J, Forman MR. Birthweight by gestational age and childhood cancer. Cancer Causes Control. August 2007;18(6):655-63.
  567. Schafmayer C, Buch S, Egberts JH, Franke A, Brosch M, El Sharawy A, u. a. Genetic investigation of DNA-repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer. 1. August 2007;121(3):555-8.
  568. Katalinic A, Bartel C, Raspe H, Schreer I. Beyond mammography screening: quality assurance in breast cancer diagnosis (The QuaMaDi Project). Br J Cancer. 15. Januar 2007;96(1):157-61.
  569. Gosepath J, Spix C, Talebloo B, Blettner M, Mann WJ. Incidence of childhood cancer of the head and neck in Germany. Ann Oncol. Oktober 2007;18(10):1716-21.
  570. Stang A, Streller B, Katalinic A, Lehnert M, Eisinger B, Kaatsch P, u. a. Incidence of skin lymphoma in Germany. Ann Epidemiol. März 2006;16(3):214-22.
  571. Spix C, Pastore G, Sankila R, Stiller CA, Steliarova-Foucher E. Neuroblastoma incidence and survival in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. September 2006;42(13):2081-91.
  572. Spallek J, Kaatsch P, Spix C, Ulusoy N, Zeeb H, Razum O. [Name-based identification of cases of Turkish origin in the childhood cancer registry in Mainz]. Gesundheitswesen. Oktober 2006;68(10):643-9.
  573. Selle B, Furtwängler R, Graf N, Kaatsch P, Bruder E, Leuschner I. Population-based study of renal cell carcinoma in children in Germany, 1980-2005: more frequently localized tumors and underlying disorders compared with adult counterparts. Cancer. 15. Dezember 2006;107(12):2906-14.
  574. Rohde V, Diemer T, Hauck E, Bestmann B, Miller J, Schröder H, u. a. Prescription practice for LH-RH analogs and androgen receptor antagonists in the treatment of advanced prostate cancer in Germany (1993-2003). Urol Int. 2006;77(4):311-6.
  575. Magnani C, Pastore G, Coebergh JW, Viscomi S, Spix C, Steliarova-Foucher E. Trends in survival after childhood cancer in Europe, 1978-1997: report from the Automated Childhood Cancer Information System project (ACCIS). Eur J Cancer. September 2006;42(13):1981-2005.
  576. Kaatsch P, Steliarova-Foucher E, Crocetti E, Magnani C, Spix C, Zambon P. Time trends of cancer incidence in European children (1978-1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. September 2006;42(13):1961-71.
  577. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International Classification of Childhood Cancer, third edition. Cancer. 1. April 2005;103(7):1457-67.
  578. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW. Trends in childhood cancer incidence in Europe, 1970-99. Lancet. 18. Juni 2005;365(9477):2088.
  579. Minkov M, Prosch H, Steiner M, Grois N, Pötschger U, Kaatsch P, u. a. Langerhans cell histiocytosis in neonates. Pediatr Blood Cancer. November 2005;45(6):802-7.
  580. Lehnert M, Eberle A, Hentschel S, Katalinic A, Kieschke J, Schmidtmann I, u. a. [Malignant melanoma of the skin as evidenced by epidemiological cancer registries in Germany -- incidence, clinical parameters, variations in recording]. Gesundheitswesen. Oktober 2005;67(10):729-35.
  581. Kaatsch P. [What happens after cancer in children?]. Dtsch Med Wochenschr. 28. Oktober 2005;Suppl 1:68.
  582. Kaatsch P, Blettner M, Spix C, Jürgens H. [Follow up of long-term survivors after childhood cancer in Germany]. Klin Padiatr. Juni 2005;217(3):169-75.
  583. Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol. 1. Juni 2005;23(16):3742-51.
  584. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, u. a. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet. 11. Dezember 2004;364(9451):2097-105.
  585. Katalinic A, Rösch C, Ludwig M. Pregnancy course and outcome after intracytoplasmic sperm injection: a controlled, prospective cohort study. Fertil Steril. Juni 2004;81(6):1604-16.
  586. Katalinic A. [Population-based cancer registration in Germany. Essentials and perspectives]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Mai 2004;47(5):422-8.
  587. Kaatsch P. [German Childhood Cancer Registry and its favorable setting]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. Mai 2004;47(5):437-43.
  588. Tannapfel A, Sommerer F, Benicke M, Katalinic A, Uhlmann D, Witzigmann H, u. a. Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma. Gut. Mai 2003;52(5):706-12.
  589. Spix C, Michaelis J, Berthold F, Erttmann R, Sander J, Schilling FH. Lead-time and overdiagnosis estimation in neuroblastoma screening. Stat Med. 30. September 2003;22(18):2877-92.
  590. Schüz J, Morgan G, Böhler E, Kaatsch P, Michaelis J. Atopic disease and childhood acute lymphoblastic leukemia. Int J Cancer. 10. Juni 2003;105(2):255-60.
  591. Schilling FH, Spix C, Berthold F, Erttmann R, Sander J, Treuner J, u. a. Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany. Cancer Lett. 18. Juli 2003;197(1-2):19-28.
  592. Klein G, Michaelis J, Spix C, Wibbing R, Eggers G, Ritter J, u. a. Second malignant neoplasms after treatment of childhood cancer. Eur J Cancer. April 2003;39(6):808-17.
  593. Katalinic A, Kunze U, Schäfer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol. Dezember 2003;149(6):1200-6.
  594. Katalinic A, Holzmann M, Kunze U. [Relation of breast cancer tumour stage and the degree of registration in a population-based cancer registry]. Gesundheitswesen. September 2003;65(8-9):509-15.
  595. Berthold F, Hero B, Kremens B, Handgretinger R, Henze G, Schilling FH, u. a. Long-term results and risk profiles of patients in five consecutive trials (1979-1997) with stage 4 neuroblastoma over 1 year of age. Cancer Lett. 18. Juli 2003;197(1-2):11-7.
  596. Tannapfel A, Sommerer F, Benicke M, Weinans L, Katalinic A, Geissler F, u. a. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma. J Pathol. August 2002;197(5):624-31.
  597. Schüz J, Kaatsch P. Epidemiology of pediatric tumors of the central nervous system. Expert Rev Neurother. Juli 2002;2(4):469-79.
  598. Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, u. a. Neuroblastoma screening at one year of age. N Engl J Med. 4. April 2002;346(14):1047-53.
  599. Rohde V, Wellmann A, Fogt F, Weidner W, Katalinic A. Economical data and advanced prostate carcinoma: do we need new guidelines for decision making? Oncol Rep. Dezember 2002;9(6):1185-8.
  600. Burkhardt-Hammer T, Spix C, Brenner H, Kaatsch P, Berthold F, Hero B, u. a. Long-term survival of children with neuroblastoma prior to the neuroblastoma screening project in Germany. Med Pediatr Oncol. September 2002;39(3):156-62.
  601. Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, u. a. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas. Oncogene. 25. Oktober 2001;20(48):7104-9.
  602. Spix C, Aareleid T, Stiller C, Magnani C, Kaatsch P, Michaelis J. Survival of children with neuroblastoma. time trends and regional differences in Europe, 1978--1992. Eur J Cancer. April 2001;37(6):722-9.
  603. Schüz J, Kaletsch U, Kaatsch P, Meinert R, Michaelis J. Risk factors for pediatric tumors of the central nervous system: results from a German population-based case-control study. Med Pediatr Oncol. Februar 2001;36(2):274-82.
  604. Schüz J, Grigat JP, Brinkmann K, Michaelis J. Residential magnetic fields as a risk factor for childhood acute leukaemia: results from a German population-based case-control study. Int J Cancer. 1. März 2001;91(5):728-35.
  605. Kaatsch P, Rickert CH, Kühl J, Schüz J, Michaelis J. Population-based epidemiologic data on brain tumors in German children. Cancer. 15. Dezember 2001;92(12):3155-64.
  606. Jaeger W, Ackermann S, Kessler H, Katalinic A, Lang N. The effect of bowel resection on survival in advanced epithelial ovarian cancer. Gynecol Oncol. November 2001;83(2):286-91.
  607. Brenner H, Kaatsch P, Burkhardt-Hammer T, Harms DO, Schrappe M, Michaelis J. Long-term survival of children with leukemia achieved by the end of the second millennium. Cancer. 1. Oktober 2001;92(7):1977-83.
  608. von Kries R, Grunert VP, Kaletsch U, Michaelis J, Göbel U. Prevention of childhood leukemia by BCG vaccination in newborns? A population-based case-control study in Lower Saxony, Germany. Pediatr Hematol Oncol. November 2000;17(7):541-50.
  609. Tannapfel A, Weinans L, Geissler F, Schütz A, Katalinic A, Köckerling F, u. a. Mutations of p53 tumor suppressor gene, apoptosis, and proliferation in intrahepatic cholangiocellular carcinoma of the liver. Dig Dis Sci. Februar 2000;45(2):317-24.
  610. Tannapfel A, Grund D, Katalinic A, Uhlmann D, Köckerling F, Haugwitz U, u. a. Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma. Int J Cancer. 20. Juli 2000;89(4):350-5.
  611. Tannapfel A, Benicke M, Katalinic A, Uhlmann D, Köckerling F, Hauss J, u. a. Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut. November 2000;47(5):721-7.
  612. Schilling FH, Berthold F, Erttmann R, Michaelis J, Spix C, Sander J, u. a. Population-based and controlled study to evaluate neuroblastoma screening at one year of age in Germany: interim results. Med Pediatr Oncol. Dezember 2000;35(6):701-4.
  613. Michaelis J, Kaletsch U, Kaatsch P. [Epidemiology of childhood brain tumors]. Zentralbl Neurochir. 2000;61(2):80-7.
  614. Löning L, Zimmermann M, Reiter A, Kaatsch P, Henze G, Riehm H, u. a. Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood. 1. Mai 2000;95(9):2770-5.
  615. Tannapfel A, Wasner M, Krause K, Geissler F, Katalinic A, Hauss J, u. a. Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. J Natl Cancer Inst. 7. Juli 1999;91(13):1154-8.
  616. Tannapfel A, Geissler F, Köckerling F, Katalinic A, Hauss J, Wittekind C. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma. J Pathol. März 1999;187(4):439-45.
  617. Tannapfel A, Engeland K, Weinans L, Katalinic A, Hauss J, Mössner J, u. a. Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver. Br J Cancer. Juni 1999;80(7):1069-74.
  618. Katalinic A, Bartel C, Uhlenkamp T, Raspe H. [Developing a small-area cancer atlas: process, validity and possible applications]. Gesundheitswesen. September 1999;61(8-9):436-8.
  619. Tannapfel A, Nüsslein S, Katalinic A, Köckerling F, Wittekind C, Fietkau R. [Proliferation and apoptosis before and after preoperative simultaneous radiochemotherapy of rectal carcinomas]. Strahlenther Onkol. Juni 1998;174(6):295-9.
  620. Tannapfel A, Nüsslein S, Fietkau R, Katalinic A, Köckerling F, Wittekind C. Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 1. Juni 1998;41(3):585-91.
  621. Fehm T, Maimonis P, Katalinic A, Jäger WH. The prognostic significance of c-erbB-2 serum protein in metastatic breast cancer. Oncology. Februar 1998;55(1):33-8.
  622. Tannapfel A, Katalinic A, Köckerling F, Wittekind C. The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables. Am J Gastroenterol. Juli 1997;92(7):1182-6.
  623. Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kühn R, Wittekind CW. Incidence of apoptosis, cell proliferation and P53 expression in renal cell carcinomas. Anticancer Res. April 1997;17(2A):1155-62.
  624. Lang E, Katalinic A, Sittl R, Dittner J, Erbe KH, Lang C, u. a. [Outpatient management of chronic pain in Middle Franconia]. Schmerz. 18. April 1997;11(2):101-7.
  625. Fehm T, Maimonis P, Weitz S, Teramoto Y, Katalinic A, Jäger W. Influence of circulating c-erbB-2 serum protein on response to adjuvant chemotherapy in node-positive breast cancer patients. Breast Cancer Res Treat. März 1997;43(1):87-95.
  626. Tannapfel A, Hahn HA, Katalinic A, Fietkau RJ, Kühn R, Wittekind CW. Prognostic value of ploidy and proliferation markers in renal cell carcinoma. Cancer. 1. Januar 1996;77(1):164-71.
  627. Seegenschmiedt MH, Klautke G, Walther E, Feldmann HJ, Katalinic A, Stuschke M, u. a. [Water-filtered infrared-A-hyperthermia combined with radiotherapy in advanced and recurrent tumors. Initial results of a multicenter phase I-II study]. Strahlenther Onkol. September 1996;172(9):475-84.
  628. Tannapfel A, Köckerling F, Katalinic A, Wittekind C. Expression of nm23-H1 predicts lymph node involvement in colorectal carcinoma. Dis Colon Rectum. Juni 1995;38(6):651-4.